CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | chromanol |
|
Accession: | CHEBI:23229
|
browse the term
|
Definition: | Any member of the class of chromanes that is chromane substituted by one or more hydroxy groups. |
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [nickel chloride results in increased expression of ABCB1 protein] |
CTD |
PMID:24448832 |
|
NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Abcd1 |
ATP binding cassette subfamily D member 1 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in decreased expression of ABCD1 mRNA] |
CTD |
PMID:29065513 |
|
NCBI chr X:157,073,860...157,095,652
Ensembl chr X:157,072,736...157,095,274
|
|
G |
Abcd3 |
ATP binding cassette subfamily D member 3 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in decreased expression of ABCD3 mRNA] |
CTD |
PMID:29065513 |
|
NCBI chr 2:225,335,708...225,389,120
Ensembl chr 2:225,335,718...225,389,120
|
|
G |
Acat1 |
acetyl-CoA acetyltransferase 1 |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [iron(II)-ascorbic acid complex results in decreased activity of ACAT1 protein] |
CTD |
PMID:10656290 |
|
NCBI chr 8:58,166,990...58,195,884
Ensembl chr 8:58,166,990...58,195,884
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [Streptozocin results in increased activity of ACHE protein] |
CTD |
PMID:19464315 |
|
NCBI chr12:22,472,358...22,477,052
Ensembl chr12:22,472,358...22,478,753
|
|
G |
Acvrl1 |
activin A receptor like type 1 |
increases expression |
EXP |
alpha-Tocopherol results in increased expression of ACVRL1 mRNA |
CTD |
PMID:16908007 |
|
NCBI chr 7:142,769,942...142,787,336
Ensembl chr 7:142,776,252...142,787,335
|
|
G |
Agt |
angiotensinogen |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [AGT protein results in increased expression of PSMC6 protein]; alpha-Tocopherol inhibits the reaction [AGT protein results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:17532611 |
|
NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B |
increases expression |
EXP |
alpha-Tocopherol results in increased expression of AKR1B1 mRNA |
CTD |
PMID:16908007 |
|
NCBI chr 4:61,706,866...61,720,959
Ensembl chr 4:61,706,864...61,720,956
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
EXP ISO |
alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in decreased phosphorylation of and results in decreased activity of AKT1 protein] alpha-Tocopherol inhibits the reaction [28-O-acetylbetulin-3-ylglucopyranoside results in decreased phosphorylation of AKT1 protein] |
CTD |
PMID:19351882 PMID:22343715 |
|
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
|
|
G |
Alad |
aminolevulinate dehydratase |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [[Streptozocin results in increased abundance of Blood Glucose] which results in decreased expression of ALAD protein] |
CTD |
PMID:7728901 |
|
NCBI chr 5:78,368,867...78,379,206
Ensembl chr 5:78,368,867...78,379,346
|
|
G |
Alas1 |
5'-aminolevulinate synthase 1 |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [Paraquat results in increased activity of ALAS1 protein] |
CTD |
PMID:12180188 |
|
NCBI chr 8:114,927,704...114,941,038
Ensembl chr 8:114,927,722...114,940,177
|
|
G |
Alb |
albumin |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [beryllium nitrate results in decreased expression of ALB protein]; sodium-4,5-dihydroxy-1,3-benzene disulfonate promotes the reaction [alpha-Tocopherol inhibits the reaction [beryllium nitrate results in decreased expression of ALB protein]] |
CTD |
PMID:17429802 |
|
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
|
|
G |
Ano6 |
anoctamin 6 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [Ozone results in increased expression of ANO6 mRNA] |
CTD |
PMID:27886375 |
|
NCBI chr 7:137,142,063...137,335,208
Ensembl chr 7:137,142,170...137,335,208
|
|
G |
Apex2 |
apurinic/apyrimidinic endodeoxyribonuclease 2 |
multiple interactions decreases expression |
EXP |
alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of APEX2 mRNA] alpha-Tocopherol results in decreased expression of APEX2 mRNA |
CTD |
PMID:26332274 |
|
NCBI chr X:23,146,085...23,166,676
Ensembl chr X:23,146,085...23,166,675
|
|
G |
Apoa1 |
apolipoprotein A1 |
decreases expression decreases activity |
ISO EXP |
alpha-Tocopherol results in decreased expression of APOA1 mRNA; alpha-Tocopherol results in decreased expression of APOA1 protein alpha-Tocopherol results in decreased activity of APOA1 promoter |
CTD |
PMID:16423621 |
|
NCBI chr 8:50,525,091...50,526,875
Ensembl chr 8:50,525,091...50,526,875
|
|
G |
Apob |
apolipoprotein B |
multiple interactions |
ISO |
alpha-Tocopherol promotes the reaction [APOB protein results in increased reduction of Copper] |
CTD |
PMID:11368321 |
|
NCBI chr 6:33,176,826...33,216,381
Ensembl chr 6:33,176,778...33,224,997
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [APP protein results in increased activity of MAPK14 protein]; alpha-Tocopherol inhibits the reaction [APP protein results in increased activity of MAPK8 protein] |
CTD |
PMID:12684028 |
|
NCBI chr11:24,425,013...24,641,872
Ensembl chr11:24,425,005...24,641,858
|
|
G |
Atf2 |
activating transcription factor 2 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased phosphorylation of ATF2 protein] |
CTD |
PMID:14645110 |
|
NCBI chr 3:60,721,137...60,795,951
Ensembl chr 3:60,721,135...60,795,951
|
|
G |
Bace1 |
beta-secretase 1 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [Oxygen deficiency results in increased expression of BACE1 mRNA] |
CTD |
PMID:19196431 |
|
NCBI chr 8:50,140,092...50,162,388
Ensembl chr 8:50,139,997...50,162,361
|
|
G |
Bad |
BCL2-associated agonist of cell death |
increases expression |
EXP |
alpha-Tocopherol results in increased expression of BAD mRNA |
CTD |
PMID:26332274 |
|
NCBI chr 1:222,198,516...222,207,459
Ensembl chr 1:222,198,534...222,207,453
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
ISO EXP |
alpha-Tocopherol affects the reaction [Lipopolysaccharides results in increased expression of BAX protein] alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in increased expression of BAX protein] alpha-Tocopherol results in increased expression of BAX mRNA |
CTD |
PMID:11805214 PMID:26332274 PMID:32134168 |
|
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
|
|
G |
Bche |
butyrylcholinesterase |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [Endosulfan results in decreased activity of BCHE protein] |
CTD |
PMID:24299906 |
|
NCBI chr 2:171,104,476...171,196,186
Ensembl chr 2:171,100,140...171,196,395
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
ISO EXP |
alpha-Tocopherol affects the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]; benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein]; DDIT3 mRNA affects the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein]; salubrinal inhibits the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein]; TNFRSF10B mRNA affects the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein] alpha-Tocopherol analog results in decreased expression of BCL2 mRNA; alpha-Tocopherol analog results in decreased expression of BCL2 protein alpha-Tocopherol inhibits the reaction [mancozeb results in decreased expression of BCL2 protein]; alpha-Tocopherol inhibits the reaction [Triiodothyronine, Reverse results in increased activity of BCL2 protein] |
CTD |
PMID:11805214 PMID:16005924 PMID:16135673 PMID:20686688 |
|
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression |
EXP |
alpha-Tocopherol results in decreased expression of BCL2L1 protein |
CTD |
PMID:18942769 |
|
NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions |
ISO |
[alpha-Tocopherol co-treated with Nimodipine] inhibits the reaction [Dibutyl Phthalate results in decreased expression of BDNF protein] |
CTD |
PMID:30776390 |
|
NCBI chr 3:100,768,637...100,819,216
Ensembl chr 3:100,768,637...100,819,210
|
|
G |
Canx |
calnexin |
affects localization increases expression |
EXP |
alpha-Tocopherol affects the localization of CANX protein alpha-Tocopherol results in increased expression of CANX mRNA; alpha-Tocopherol results in increased expression of CANX protein |
CTD |
PMID:16908007 |
|
NCBI chr10:35,800,942...35,833,939
Ensembl chr10:35,800,942...35,833,861
|
|
G |
Casp3 |
caspase 3 |
multiple interactions decreases activity |
ISO EXP |
[alpha-Tocopherol co-treated with beta-ionone] results in increased activity of CASP3 protein; [alpha-Tocopherol co-treated with Tretinoin] results in increased activity of CASP3 protein; alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Acetaldehyde results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [cholest-5-en-3 beta,7 alpha-diol results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Galactosamine results in increased cleavage of and results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [S-(1,2-dichlorovinyl)cysteine results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Vitamin A results in increased activity of CASP3 protein]; alpha-Tocopherol promotes the reaction [Amiodarone results in increased activity of CASP3 protein]; alpha-Tocopherol promotes the reaction [beta Carotene metabolite results in decreased activity of CASP3 protein]; alpha-Tocopherol promotes the reaction [TNF protein promotes the reaction [Amiodarone results in increased activity of CASP3 protein]]; alpha-Tocopherol results in increased cleavage of and results in increased activity of CASP3 protein [alpha-Tocopherol co-treated with Nimodipine] inhibits the reaction [Dibutyl Phthalate results in increased expression of CASP3 protein]; alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in increased cleavage of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of CASP3 protein] [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Diclofenac results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in increased expression of CASP3 protein] alpha-Tocopherol results in decreased activity of CASP3 protein |
CTD |
PMID:12450566 PMID:14599462 PMID:14722101 PMID:15095415 PMID:17618090 PMID:17874176 PMID:17936189 PMID:21869839 PMID:22389237 PMID:23042730 PMID:29065513 PMID:29129777 PMID:30776390 PMID:31712109 PMID:32134168 |
|
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Casp7 |
caspase 7 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [S-(1,2-dichlorovinyl)cysteine results in increased activity of CASP7 protein]; alpha-Tocopherol promotes the reaction [Amiodarone results in increased activity of CASP7 protein]; alpha-Tocopherol promotes the reaction [TNF protein promotes the reaction [Amiodarone results in increased activity of CASP7 protein]] |
CTD |
PMID:23042730 PMID:29129777 |
|
NCBI chr 1:277,190,557...277,242,779
Ensembl chr 1:277,190,964...277,242,774
|
|
G |
Casp8 |
caspase 8 |
increases cleavage |
ISO |
alpha-Tocopherol analog results in increased cleavage of CASP8 protein |
CTD |
PMID:20686688 |
|
NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106
|
|
G |
Casp9 |
caspase 9 |
increases cleavage multiple interactions |
ISO |
alpha-Tocopherol analog results in increased cleavage of CASP9 protein alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of CASP9 protein] alpha-Tocopherol results in increased cleavage of and results in increased activity of CASP9 protein |
CTD |
PMID:20686688 PMID:21869839 PMID:31712109 |
|
NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
|
|
G |
Cat |
catalase |
multiple interactions increases activity increases expression |
EXP ISO |
[Ascorbic Acid co-treated with beta Carotene co-treated with alpha-Tocopherol co-treated with Sodium Selenite] inhibits the reaction [Galactosamine results in increased activity of CAT protein]; [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; [Sodium Selenite co-treated with alpha-Tocopherol] inhibits the reaction [bisphenol A results in decreased activity of CAT protein]; alpha-Tocopherol affects the reaction [Copper Sulfate results in decreased activity of CAT protein]; alpha-Tocopherol affects the reaction [flubendiamide results in decreased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [cholestane-3,5,6-triol results in decreased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [Malathion results in increased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [Streptozocin results in decreased expression of CAT protein] alpha-Tocopherol results in increased activity of CAT protein alpha-Tocopherol results in increased expression of CAT protein alpha-Tocopherol results in increased expression of CAT mRNA; alpha-Tocopherol results in increased expression of CAT protein |
CTD |
PMID:9306888 PMID:16979807 PMID:18547560 PMID:19083475 PMID:19464315 PMID:19941068 PMID:20194575 PMID:21322096 PMID:22732938 PMID:27823922 PMID:30057697 PMID:31022331 |
|
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
|
|
G |
Cav1 |
caveolin 1 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 mRNA] |
CTD |
PMID:27257344 |
|
NCBI chr 4:44,597,123...44,630,206
Ensembl chr 4:44,597,123...44,630,200
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO EXP |
alpha-Tocopherol inhibits the reaction [Vitamin E deficiency results in increased expression of CCL2 protein] alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of CCL2 mRNA]; alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] |
CTD |
PMID:19735175 PMID:24333275 PMID:26332274 |
|
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of CCND1 mRNA] |
CTD |
PMID:26332274 |
|
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
|
|
G |
Ccnd2 |
cyclin D2 |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of CCND2 mRNA] |
CTD |
PMID:26332274 |
|
NCBI chr 4:159,674,885...159,697,207
Ensembl chr 4:159,674,885...159,697,207
|
|
G |
Cd36 |
CD36 molecule |
affects expression multiple interactions |
EXP |
alpha-Tocopherol affects the expression of CD36 mRNA alpha-Tocopherol inhibits the reaction [[troglitazone co-treated with Ethanol] results in increased expression of CD36 protein] |
CTD |
PMID:16407258 |
|
NCBI chr 4:14,150,309...14,191,498
Ensembl chr 4:14,001,761...14,249,749
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions decreases expression |
EXP |
alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of CDKN1A mRNA] alpha-Tocopherol results in decreased expression of CDKN1A mRNA |
CTD |
PMID:26332274 |
|
NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
|
|
G |
Cftr |
CF transmembrane conductance regulator |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [Cadmium results in decreased expression of CFTR protein] |
CTD |
PMID:20363832 |
|
NCBI chr 4:42,693,263...42,860,679
Ensembl chr 4:42,692,836...42,860,676
|
|
G |
Chat |
choline O-acetyltransferase |
multiple interactions |
EXP |
[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in increased expression of CHAT protein; Tobacco Smoke Pollution inhibits the reaction [[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in increased expression of CHAT protein] |
CTD |
PMID:25891525 |
|
NCBI chr16:8,576,858...8,686,131
Ensembl chr16:8,577,840...8,686,131
|
|
G |
Clcn3 |
chloride voltage-gated channel 3 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [Ozone results in increased expression of CLCN3 mRNA] |
CTD |
PMID:27886375 |
|
NCBI chr16:32,448,821...32,520,649
Ensembl chr16:32,449,116...32,519,148
|
|
G |
Cldn2 |
claudin 2 |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [Potassium Dichromate affects the localization of CLDN2 protein] |
CTD |
PMID:19766176 |
|
NCBI chr X:111,122,552...111,133,188
Ensembl chr X:111,122,552...111,137,769
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
multiple interactions increases expression |
ISO |
alpha-Tocopherol inhibits the reaction [Galactosamine results in decreased expression of CPT1A mRNA]; alpha-Tocopherol promotes the reaction [NR1I2 results in increased expression of CPT1A mRNA] alpha-Tocopherol results in increased expression of CPT1A mRNA |
CTD |
PMID:17936189 |
|
NCBI chr 1:218,568,157...218,629,679
Ensembl chr 1:218,569,510...218,629,678
|
|
G |
Crabp2 |
cellular retinoic acid binding protein 2 |
multiple interactions |
ISO |
[Tretinoin co-treated with alpha-Tocopherol] results in increased expression of CRABP2 mRNA; [Tretinoin co-treated with alpha-Tocopherol] results in increased expression of CRABP2 protein |
CTD |
PMID:15225641 |
|
NCBI chr 2:187,322,416...187,326,794
Ensembl chr 2:184,882,969...184,883,505
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions |
ISO |
[alpha-Tocopherol co-treated with Nimodipine] inhibits the reaction [Dibutyl Phthalate results in decreased phosphorylation of CREB1 protein] |
CTD |
PMID:30776390 |
|
NCBI chr 9:71,229,753...71,298,994
Ensembl chr 9:71,230,108...71,293,435
|
|
G |
Crp |
C-reactive protein |
multiple interactions |
ISO |
[alpha-Tocopherol co-treated with gamma-Tocopherol] results in decreased expression of CRP protein |
CTD |
PMID:18191645 |
|
NCBI chr13:91,080,448...91,081,358
Ensembl chr13:91,054,974...91,093,713
|
|
G |
Cryaa |
crystallin, alpha A |
increases expression |
EXP |
alpha-Tocopherol results in increased expression of CRYAA mRNA |
CTD |
PMID:16908007 |
|
NCBI chr20:10,438,444...10,442,189
Ensembl chr20:10,438,444...10,442,187
|
|
G |
Ctsd |
cathepsin D |
increases expression |
EXP |
alpha-Tocopherol results in increased expression of CTSD protein |
CTD |
PMID:18942769 |
|
NCBI chr 1:215,541,570...215,553,446
Ensembl chr 1:215,541,542...215,553,451
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL1 mRNA] |
CTD |
PMID:24333275 |
|
NCBI chr14:18,743,678...18,745,457
Ensembl chr14:18,743,685...18,745,457
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL2 mRNA] |
CTD |
PMID:24333275 |
|
NCBI chr14:18,731,346...18,733,391
Ensembl chr14:18,731,378...18,733,391
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression multiple interactions |
EXP |
alpha-Tocopherol results in increased expression of CYP1A1 mRNA [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of CYP1A1 mRNA]; alpha-Tocopherol results in increased expression of and results in increased activity of CYP1A1 protein |
CTD |
PMID:15665910 PMID:22389237 |
|
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases activity multiple interactions |
EXP ISO |
alpha-Tocopherol results in increased activity of CYP1A2 protein alpha-Tocopherol inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of CYP1A2 mRNA] |
CTD |
PMID:15665910 PMID:26102010 |
|
NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
decreases expression |
ISO |
alpha-Tocopherol results in decreased expression of CYP2B10 mRNA |
CTD |
PMID:26102010 |
|
NCBI chr 7:99,142,431...99,183,540
Ensembl chr 7:99,142,450...99,181,783
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
decreases expression |
ISO |
alpha-Tocopherol results in decreased expression of CYP2B9 mRNA |
CTD |
PMID:26102010 |
|
NCBI chr 1:83,163,103...83,236,615
Ensembl chr 1:83,163,079...83,236,615
|
|
G |
Cyp2c79 |
cytochrome P450, family 2, subfamily c, polypeptide 79 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of CYP2C29 protein] |
CTD |
PMID:26102010 |
|
NCBI chr 1:147,236,480...147,307,988
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
increases expression multiple interactions |
EXP ISO |
alpha-Tocopherol results in increased expression of CYP2E1 mRNA [Methionine co-treated with Thiamine co-treated with Niacinamide co-treated with alpha-Tocopherol co-treated with Zinc] inhibits the reaction [[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased activity of CYP2E1 protein]; [Methionine co-treated with Thiamine co-treated with Niacinamide co-treated with alpha-Tocopherol co-treated with Zinc] inhibits the reaction [[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased expression of CYP2E1 mRNA]; alpha-Tocopherol promotes the reaction [Acrylonitrile results in increased expression of CYP2E1 mRNA] |
CTD |
PMID:26332274 PMID:27919644 PMID:28062356 |
|
NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
EXP |
[Methionine co-treated with Thiamine co-treated with Niacinamide co-treated with alpha-Tocopherol co-treated with Zinc] inhibits the reaction [[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased expression of CYP3A2 mRNA] |
CTD |
PMID:27919644 |
|
NCBI chr12:11,641,500...11,677,818
Ensembl chr12:11,655,402...11,733,136
|
|
G |
Cyp3a62 |
cytochrome P450, family 3, subfamily a, polypeptide 62 |
increases expression multiple interactions |
ISO |
alpha-Tocopherol results in increased expression of CYP3A4 mRNA alpha-Tocopherol inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Testosterone]; alpha-Tocopherol inhibits the reaction [Galactosamine results in decreased expression of CYP3A4 mRNA]; Galactosamine inhibits the reaction [alpha-Tocopherol results in increased expression of CYP3A4 mRNA] |
CTD |
PMID:17936189 PMID:31102695 |
|
NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
increases expression multiple interactions |
ISO |
alpha-Tocopherol results in increased expression of CYP3A13 mRNA; alpha-Tocopherol results in increased expression of CYP3A13 protein alpha-Tocopherol inhibits the reaction [CYP3A5 protein results in increased hydroxylation of Testosterone] |
CTD |
PMID:26102010 PMID:31102695 |
|
NCBI chr12:19,074,288...19,114,491
Ensembl chr12:19,074,583...19,114,399
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions increases expression |
EXP ISO |
alpha-Tocopherol inhibits the reaction [Cadmium Chloride results in increased expression of DDIT3 mRNA] alpha-Tocopherol analog results in increased expression of DDIT3 protein benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [alpha-Tocopherol analog results in increased expression of DDIT3 protein]; DDIT3 mRNA affects the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein]; salubrinal inhibits the reaction [alpha-Tocopherol analog results in increased expression of DDIT3 protein] |
CTD |
PMID:20459685 PMID:20686688 |
|
NCBI chr 7:70,578,564...70,585,074
Ensembl chr 7:70,580,198...70,585,084
|
|
G |
Diablo |
diablo, IAP-binding mitochondrial protein |
affects localization |
ISO |
alpha-Tocopherol affects the localization of DIABLO protein |
CTD |
PMID:15582575 |
|
NCBI chr12:38,490,230...38,503,344
Ensembl chr12:38,490,230...38,503,330
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
increases phosphorylation multiple interactions |
ISO |
alpha-Tocopherol analog results in increased phosphorylation of EIF2A protein benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of EIF2A protein]; salubrinal inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of EIF2A protein] |
CTD |
PMID:20686688 |
|
NCBI chr 2:148,722,343...148,755,781
Ensembl chr 2:148,722,231...148,755,520
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR1 protein] |
CTD |
PMID:22389237 |
|
NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR2 mRNA] |
CTD |
PMID:22389237 |
|
NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251
|
|
G |
Faslg |
Fas ligand |
increases expression |
EXP |
alpha-Tocopherol results in increased expression of FASLG mRNA |
CTD |
PMID:26332274 |
|
NCBI chr13:79,696,811...79,717,581
Ensembl chr13:79,698,445...79,705,705
|
|
G |
Fbl |
fibrillarin |
decreases expression |
EXP |
alpha-Tocopherol deficiency results in decreased expression of FBL protein |
CTD |
PMID:15247049 |
|
NCBI chr 1:85,103,519...85,112,619
Ensembl chr 1:85,103,519...85,112,619
|
|
G |
Fmo1 |
flavin containing dimethylaniline monoxygenase 1 |
increases expression |
EXP |
alpha-Tocopherol results in increased expression of FMO1 mRNA |
CTD |
PMID:16908007 |
|
NCBI chr13:80,712,885...80,745,095
Ensembl chr13:80,712,882...80,745,347
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [Glucose results in increased expression of and results in increased secretion of FN1 protein] |
CTD |
PMID:9225831 |
|
NCBI chr 9:78,900,111...78,969,018
Ensembl chr 9:78,900,103...78,969,078
|
|
G |
Fyn |
FYN proto-oncogene, Src family tyrosine kinase |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [bis(2-hydroxy-2-ethylbutanoato)oxochromate(V) results in increased phosphorylation of FYN protein]; alpha-Tocopherol inhibits the reaction [Potassium Dichromate results in increased phosphorylation of FYN protein] |
CTD |
PMID:14572611 |
|
NCBI chr20:44,436,354...44,630,316
Ensembl chr20:44,436,403...44,630,317
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression |
EXP |
alpha-Tocopherol results in increased expression of GADD45A mRNA |
CTD |
PMID:26332274 |
|
NCBI chr 4:97,782,512...97,784,814
Ensembl chr 4:97,782,512...97,784,842
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions |
ISO |
[alpha-Tocopherol co-treated with Paraquat] results in increased expression of GCLC mRNA |
CTD |
PMID:24530478 |
|
NCBI chr 8:85,059,051...85,097,471
Ensembl chr 8:85,059,051...85,097,468
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
multiple interactions |
EXP ISO |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GCLM mRNA] [alpha-Tocopherol co-treated with Paraquat] results in increased expression of GCLM mRNA |
CTD |
PMID:22389237 PMID:24530478 |
|
NCBI chr 2:225,827,504...225,847,876
Ensembl chr 2:225,827,504...225,847,874
|
|
G |
Gfap |
glial fibrillary acidic protein |
increases expression |
EXP |
alpha-Tocopherol results in increased expression of GFAP protein |
CTD |
PMID:18942769 |
|
NCBI chr10:90,990,762...90,999,435
Ensembl chr10:90,990,762...90,999,506
|
|
G |
Gnai2 |
G protein subunit alpha i2 |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [Glucose results in decreased expression of GNAI2 protein] |
CTD |
PMID:18441196 |
|
NCBI chr 8:116,370,730...116,391,337
Ensembl chr 8:116,370,744...116,391,307
|
|
G |
Gnai3 |
G protein subunit alpha i3 |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [Glucose results in decreased expression of GNAI3 protein] |
CTD |
PMID:18441196 |
|
NCBI chr 2:210,896,779...210,934,733
Ensembl chr 2:210,896,656...210,934,749
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [beryllium nitrate results in increased activity of GPT protein] |
CTD |
PMID:17429802 |
|
NCBI chr 7:117,759,083...117,761,932
Ensembl chr 7:117,759,083...117,761,931
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [Sodium Selenite results in increased expression of GPX4 mRNA] |
CTD |
PMID:14642406 |
|
NCBI chr 7:12,516,357...12,519,154
Ensembl chr 7:12,516,352...12,519,154
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of GSR protein] |
CTD |
PMID:16979807 |
|
NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GSTM1 mRNA] |
CTD |
PMID:22389237 |
|
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
increases expression |
EXP |
alpha-Tocopherol results in increased expression of GSTT1 protein |
CTD |
PMID:9855024 |
|
NCBI chr20:13,799,102...13,816,527
Ensembl chr20:13,799,102...13,816,526
|
|
G |
Gusb |
glucuronidase, beta |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [cumene hydroperoxide results in decreased uptake of GUSB protein]; alpha-Tocopherol inhibits the reaction [cumene hydroperoxide results in increased secretion of GUSB protein] |
CTD |
PMID:19135433 |
|
NCBI chr12:30,202,066...30,215,583
Ensembl chr12:30,198,822...30,227,771
|
|
G |
Hal |
histidine ammonia lyase |
increases expression |
EXP |
alpha-Tocopherol results in increased expression of HAL mRNA |
CTD |
PMID:16908007 |
|
NCBI chr 7:34,326,087...34,356,413
Ensembl chr 7:34,326,087...34,356,413
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
multiple interactions |
EXP |
[Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Cadmium results in increased activity of HMGCR protein]; [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in increased activity of HMGCR protein] |
CTD |
PMID:19595682 PMID:21535577 |
|
NCBI chr 2:27,480,224...27,500,654
Ensembl chr 2:27,480,226...27,500,654
|
|
G |
Hmox1 |
heme oxygenase 1 |
affects expression multiple interactions |
ISO EXP |
alpha-Tocopherol affects the expression of HMOX1 mRNA [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of HMOX1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of HMOX1 protein]; alpha-Tocopherol inhibits the reaction [Paraquat results in increased activity of HMOX1 protein] alpha-Tocopherol inhibits the reaction [benzo(a)pyrene-7,8-dione results in increased expression of HMOX1 protein] |
CTD |
PMID:8743975 PMID:12180188 PMID:22053912 PMID:22389237 |
|
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
|
|
G |
Hp |
haptoglobin |
affects activity multiple interactions |
ISO |
alpha-Tocopherol affects the activity of HP protein polymorphism Ascorbic Acid inhibits the reaction [alpha-Tocopherol affects the activity of HP protein polymorphism] |
CTD |
PMID:19769483 |
|
NCBI chr19:42,096,255...42,100,805
Ensembl chr19:42,097,995...42,100,804
|
|
G |
Hsd17b3 |
hydroxysteroid (17-beta) dehydrogenase 3 |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in decreased expression of HSD17B3 mRNA] |
CTD |
PMID:32134168 |
|
NCBI chr17:1,579,319...1,610,745
Ensembl chr17:1,579,319...1,610,745
|
|
G |
Hsd3b2 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in decreased expression of HSD3B2 mRNA] |
CTD |
PMID:32134168 |
|
NCBI chr 2:200,712,895...200,722,429
Ensembl chr 2:202,341,422...202,350,929
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
increases expression |
EXP |
alpha-Tocopherol results in increased expression of HSPA1B mRNA |
CTD |
PMID:16908007 |
|
NCBI chr20:4,877,638...4,880,112
Ensembl chr20:2,699,712...2,701,815
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
[Ascorbic Acid co-treated with lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; alpha-Tocopherol inhibits the reaction [Vehicle Emissions results in increased expression of ICAM1 protein] |
CTD |
PMID:22313677 PMID:25551565 |
|
NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with Lipopolysaccharides] results in increased expression of IFNG mRNA; alpha-Tocopherol results in decreased susceptibility to [IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] |
CTD |
PMID:16307444 PMID:24333275 |
|
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
|
|
G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of IGFBP5 mRNA |
CTD |
PMID:23859036 |
|
NCBI chr 9:80,154,230...80,166,813
Ensembl chr 9:80,150,211...80,167,033
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
ISO EXP |
[Ascorbic Acid co-treated with lycopene co-treated with alpha-Tocopherol] promotes the reaction [TNF protein results in increased expression of and results in increased secretion of IL10 protein]; alpha-Tocopherol promotes the reaction [TNF protein results in increased expression of and results in increased secretion of IL10 protein] [alpha-Tocopherol co-treated with Lipopolysaccharides] results in increased expression of IL10 mRNA |
CTD |
PMID:24333275 PMID:25551565 |
|
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [Hexachlorocyclohexane results in increased expression of IL1A mRNA]; alpha-Tocopherol inhibits the reaction [Hexachlorocyclohexane results in increased expression of IL1A protein] |
CTD |
PMID:15025948 |
|
NCBI chr 3:121,824,712...121,836,122
Ensembl chr 3:121,825,412...121,836,086
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO EXP |
alpha-Tocopherol inhibits the reaction [cumene hydroperoxide results in increased secretion of IL1B protein]; alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of IL1B protein]; alpha-Tocopherol inhibits the reaction [Vitamin E deficiency results in increased expression of IL1B mRNA] alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of IL1B mRNA] |
CTD |
PMID:19135433 PMID:19735175 PMID:26332274 PMID:31712109 |
|
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO EXP |
alpha-Tocopherol inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of and results in increased secretion of IL6 protein] alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in increased expression of IL6 protein] alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] |
CTD |
PMID:15630180 PMID:24296301 PMID:32134168 |
|
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions increases expression |
ISO |
alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased phosphorylation of JUN protein] alpha-Tocopherol results in increased expression of JUN mRNA; alpha-Tocopherol results in increased expression of JUN protein |
CTD |
PMID:14645110 PMID:19000923 PMID:20025956 |
|
NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [Glucose results in decreased activity of KCNH2 protein] |
CTD |
PMID:12531891 |
|
NCBI chr 4:7,355,066...7,387,282
Ensembl chr 4:7,355,574...7,387,253
|
|
G |
Lcat |
lecithin cholesterol acyltransferase |
multiple interactions |
EXP |
[Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Cadmium results in decreased activity of LCAT protein]; [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein] |
CTD |
PMID:19595682 PMID:21535577 |
|
NCBI chr19:37,913,333...37,916,799
Ensembl chr19:37,913,336...37,916,813
|
|
G |
Lck |
LCK proto-oncogene, Src family tyrosine kinase |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [bis(2-hydroxy-2-ethylbutanoato)oxochromate(V) results in increased phosphorylation of LCK protein]; alpha-Tocopherol inhibits the reaction [Potassium Dichromate results in increased phosphorylation of LCK protein] |
CTD |
PMID:14572611 |
|
NCBI chr 5:147,750,976...147,779,627
Ensembl chr 5:147,750,973...147,761,983
|
|
G |
Ldha |
lactate dehydrogenase A |
multiple interactions |
EXP |
[Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in increased expression of LDHA protein] |
CTD |
PMID:21322096 |
|
NCBI chr 1:102,900,288...102,909,713
Ensembl chr 1:102,900,286...102,909,707
|
|
G |
Ldhb |
lactate dehydrogenase B |
multiple interactions |
EXP |
[Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in increased expression of LDHB protein] |
CTD |
PMID:21322096 |
|
NCBI chr 4:176,701,980...176,719,999
Ensembl chr 4:176,701,983...176,720,012
|
|
G |
Lyn |
LYN proto-oncogene, Src family tyrosine kinase |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [bis(2-hydroxy-2-ethylbutanoato)oxochromate(V) results in increased phosphorylation of LYN protein]; alpha-Tocopherol inhibits the reaction [Potassium Dichromate results in increased phosphorylation of LYN protein] |
CTD |
PMID:14572611 |
|
NCBI chr 5:16,526,058...16,642,648
Ensembl chr 5:16,526,058...16,642,648
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions affects activity |
ISO EXP |
alpha-Tocopherol inhibits the reaction [Tamoxifen results in decreased phosphorylation of MAPK1 protein] [Nimodipine co-treated with alpha-Tocopherol] inhibits the reaction [Dibutyl Phthalate results in increased expression of and results in increased phosphorylation of MAPK1 protein]; alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of MAPK1 protein] [alpha-Tocopherol affects the activity of MAPK1 protein] which results in decreased susceptibility to Potassium Dichromate |
CTD |
PMID:17011908 PMID:19766176 PMID:30776390 |
|
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [[4-hydroxy-2-nonenal co-treated with Hydrogen Peroxide] results in increased activity of MAPK14 protein]; alpha-Tocopherol inhibits the reaction [APP protein results in increased activity of MAPK14 protein]; alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased activity of MAPK14 protein] |
CTD |
PMID:12684028 PMID:14645110 |
|
NCBI chr20:5,933,290...5,995,137
Ensembl chr20:5,933,303...5,995,137
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions affects activity |
ISO EXP |
alpha-Tocopherol inhibits the reaction [Tamoxifen results in decreased phosphorylation of MAPK3 protein]; alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased activity of MAPK3 protein] [Nimodipine co-treated with alpha-Tocopherol] inhibits the reaction [Dibutyl Phthalate results in increased expression of and results in increased phosphorylation of MAPK3 protein]; alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of MAPK3 protein] [alpha-Tocopherol affects the activity of MAPK3 protein] which results in decreased susceptibility to Potassium Dichromate |
CTD |
PMID:14645110 PMID:17011908 PMID:19766176 PMID:30776390 |
|
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions increases phosphorylation |
ISO |
alpha-Tocopherol inhibits the reaction [APP protein results in increased activity of MAPK8 protein]; alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased activity of MAPK8 protein]; benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of MAPK8 protein]; salubrinal inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:12684028 PMID:14645110 PMID:20686688 |
|
NCBI chr16:9,620,854...9,709,342
Ensembl chr16:9,625,177...9,709,347
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
increases phosphorylation multiple interactions |
ISO |
alpha-Tocopherol analog results in increased phosphorylation of MAPK9 protein benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of MAPK9 protein]; salubrinal inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of MAPK9 protein] |
CTD |
PMID:20686688 |
|
NCBI chr10:35,333,859...35,374,364
Ensembl chr10:35,333,859...35,374,355
|
|
G |
Mb |
myoglobin |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [MB modified form results in decreased secretion of very low density lipoprotein triglyceride] |
CTD |
PMID:17478120 |
|
NCBI chr 7:118,101,633...118,108,864
Ensembl chr 7:118,101,634...118,108,864
|
|
G |
Mbp |
myelin basic protein |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased expression of MBP protein] |
CTD |
PMID:14645110 |
|
NCBI chr18:79,326,738...79,437,310
Ensembl chr18:79,326,738...79,437,310
|
|
G |
Mgat3 |
beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase |
increases expression |
EXP |
alpha-Tocopherol results in increased expression of MGAT3 mRNA |
CTD |
PMID:16908007 |
|
NCBI chr 7:121,394,541...121,436,935
Ensembl chr 7:121,408,829...121,435,022
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of MKI67 mRNA |
CTD |
PMID:23859036 |
|
NCBI chr 1:207,993,895...208,020,454
Ensembl chr 1:207,993,895...208,020,454
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
EXP |
[Ascorbic Acid co-treated with beta Carotene co-treated with alpha-Tocopherol co-treated with Sodium Selenite] inhibits the reaction [Galactosamine results in increased activity of MPO protein] |
CTD |
PMID:31022331 |
|
NCBI chr10:75,087,892...75,098,260
Ensembl chr10:75,087,892...75,098,260
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased expression of MUC5AC mRNA] |
CTD |
PMID:24333275 |
|
NCBI chr 1:214,725,482...214,756,653
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [mancozeb results in decreased expression of MYC protein] |
CTD |
PMID:16005924 |
|
NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
|
|
G |
Nefh |
neurofilament heavy |
increases expression |
EXP |
alpha-Tocopherol results in increased expression of NEFH protein modified form |
CTD |
PMID:18942769 |
|
NCBI chr14:85,181,572...85,191,557
Ensembl chr14:85,181,572...85,191,557
|
|
G |
Nfe2l2 |
nuclear factor, erythroid 2-like 2 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NFE2L2 protein]; [alpha-Tocopherol co-treated with Hydrogen Peroxide] affects the localization of NFE2L2 protein; alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in decreased expression of NFE2L2 protein] |
CTD |
PMID:22389237 PMID:31412289 PMID:32134168 |
|
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions increases activity |
EXP ISO |
alpha-Tocopherol inhibits the reaction [Hexachlorocyclohexane results in increased activity of NFKB1 protein]; alpha-Tocopherol inhibits the reaction [Triiodothyronine, Reverse results in increased activity of [NFKB1 protein binds to RELA protein]] alpha-Tocopherol inhibits the reaction [Galactosamine results in increased activity of [NFKB1 protein binds to NFKB1 protein]]; alpha-Tocopherol inhibits the reaction [Galactosamine results in increased activity of [RELA protein binds to NFKB1 protein]] alpha-Tocopherol results in increased activity of NFKB1 protein |
CTD |
PMID:15025948 PMID:16135673 PMID:17936189 PMID:19083475 |
|
NCBI chr 2:240,773,520...240,890,053
Ensembl chr 2:240,773,456...240,866,689
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO EXP |
alpha-Tocopherol inhibits the reaction [AGT protein results in increased phosphorylation of NFKBIA protein]; alpha-Tocopherol inhibits the reaction [DCD protein results in increased phosphorylation of NFKBIA protein] [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of NFKBIA mRNA]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of NFKBIA mRNA] alpha-Tocopherol inhibits the reaction [Triiodothyronine, Reverse results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:16135673 PMID:17532611 PMID:25551565 |
|
NCBI chr 6:76,267,227...76,270,457
Ensembl chr 6:76,267,228...76,270,457
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [cumene hydroperoxide results in increased expression of NOS2 protein] alpha-Tocopherol inhibits the reaction [Galactosamine results in increased expression of NOS2 mRNA] |
CTD |
PMID:17936189 PMID:19135433 |
|
NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
|
|
G |
Nos3 |
nitric oxide synthase 3 |
increases expression |
ISO |
alpha-Tocopherol results in increased expression of NOS3 mRNA; alpha-Tocopherol results in increased expression of NOS3 protein |
CTD |
PMID:16949522 |
|
NCBI chr 4:7,321,908...7,342,404
Ensembl chr 4:7,320,668...7,342,410
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NQO1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NQO1 protein] |
CTD |
PMID:22389237 |
|
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO |
alpha-Tocopherol promotes the reaction [NR1I2 results in increased expression of CPT1A mRNA] |
CTD |
PMID:17936189 |
|
NCBI chr11:65,022,100...65,058,546
Ensembl chr11:65,022,100...65,058,545
|
|
G |
Ogdh |
oxoglutarate dehydrogenase |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [sodium arsenite results in decreased activity of OGDH protein] |
CTD |
PMID:12915223 |
|
NCBI chr14:86,414,924...86,481,903
Ensembl chr14:86,414,949...86,613,327
|
|
G |
Orm1 |
orosomucoid 1 |
increases expression |
ISO |
alpha-Tocopherol results in increased expression of ORM1 mRNA; alpha-Tocopherol results in increased expression of ORM1 protein |
CTD |
PMID:19000923 PMID:20025956 |
|
NCBI chr 5:79,179,668...79,182,820
Ensembl chr 5:79,179,417...79,182,820
|
|
G |
Park7 |
Parkinsonism associated deglycase |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [Rotenone affects the localization of PARK7 protein] |
CTD |
PMID:16439141 |
|
NCBI chr 5:167,982,438...168,004,724
Ensembl chr 5:167,982,439...168,004,724
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO EXP |
alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased cleavage of PARP1 protein] alpha-Tocopherol inhibits the reaction [nickel chloride results in increased cleavage of PARP1 protein] |
CTD |
PMID:14645110 PMID:24448832 |
|
NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
|
|
G |
Pawr |
pro-apoptotic WT1 regulator |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [Nerve Growth Factors deficiency results in increased expression of PAWR mRNA]; alpha-Tocopherol inhibits the reaction [Nerve Growth Factors deficiency results in increased expression of PAWR protein] |
CTD |
PMID:10428045 |
|
NCBI chr 7:51,273,764...51,353,700
Ensembl chr 7:51,273,771...51,353,068
|
|
G |
Pax3 |
paired box 3 |
multiple interactions increases expression |
ISO |
alpha-Tocopherol inhibits the reaction [Glucose results in decreased expression of PAX3 mRNA] alpha-Tocopherol results in increased expression of PAX3 mRNA |
CTD |
PMID:12739027 |
|
NCBI chr 9:84,004,004...84,101,226
Ensembl chr 9:84,005,183...84,101,172
|
|
G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 |
decreases expression |
EXP |
alpha-Tocopherol results in decreased expression of PCK1 mRNA |
CTD |
PMID:11597575 |
|
NCBI chr 3:171,213,936...171,219,885
Ensembl chr 3:171,213,936...171,219,871
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PCNA protein] |
CTD |
PMID:22389237 |
|
NCBI chr 3:124,880,698...124,884,570
Ensembl chr 3:124,880,698...124,884,570
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of PDGFRB mRNA; [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of PDGFRB protein |
CTD |
PMID:23859036 |
|
NCBI chr18:56,364,586...56,406,381
Ensembl chr18:56,364,620...56,406,381
|
|
G |
Pgk1 |
phosphoglycerate kinase 1 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in increased expression of PGK1 protein] |
CTD |
PMID:18603805 |
|
NCBI chr X:77,263,399...77,279,373
Ensembl chr X:77,263,359...77,279,367
|
|
G |
Plg |
plasminogen |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [Arsenic promotes the reaction [Humic Substances results in decreased activity of PLG protein]]; alpha-Tocopherol inhibits the reaction [Humic Substances results in decreased activity of PLG protein] |
CTD |
PMID:11419606 |
|
NCBI chr 1:48,521,828...48,563,895
Ensembl chr 1:48,521,772...48,563,776
|
|
G |
Pltp |
phospholipid transfer protein |
decreases abundance |
ISO |
PLTP mutant form results in decreased abundance of alpha-Tocopherol |
CTD |
PMID:16675720 |
|
NCBI chr 3:161,304,469...161,322,289
Ensembl chr 3:161,304,469...161,322,289
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions increases expression |
ISO |
alpha-Tocopherol inhibits the reaction [Galactosamine results in decreased expression of PPARA mRNA] alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in decreased expression of PPARA mRNA] alpha-Tocopherol results in increased expression of PPARA mRNA |
CTD |
PMID:17936189 PMID:29065513 |
|
NCBI chr 7:126,618,872...126,687,282
Ensembl chr 7:126,619,196...126,681,752
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
increases expression multiple interactions increases activity |
ISO EXP |
alpha-Tocopherol results in increased expression of PPARG mRNA; alpha-Tocopherol results in increased expression of PPARG protein [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein] alpha-Tocopherol results in increased activity of PPARG protein |
CTD |
PMID:11752099 PMID:14521714 PMID:19083475 PMID:22389237 PMID:28062356 |
|
NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380
|
|
G |
Ppia |
peptidylprolyl isomerase A |
increases expression |
EXP |
alpha-Tocopherol results in increased expression of PPIA mRNA |
CTD |
PMID:16908007 |
|
NCBI chr14:86,673,775...86,677,443
Ensembl chr14:86,673,775...86,677,443
|
|
G |
Psmc6 |
proteasome 26S subunit, ATPase 6 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [AGT protein results in increased expression of PSMC6 protein] |
CTD |
PMID:17532611 |
|
NCBI chr15:19,667,453...19,688,916
Ensembl chr15:19,667,453...19,688,914
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
decreases activity multiple interactions |
ISO EXP |
alpha-Tocopherol metabolite results in decreased activity of PTGS2 protein; alpha-Tocopherol results in decreased activity of PTGS2 protein [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PTGS2 protein] |
CTD |
PMID:15225597 PMID:22389237 |
|
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
affects localization multiple interactions |
ISO EXP |
alpha-Tocopherol affects the localization of RELA protein alpha-Tocopherol inhibits the reaction [Galactosamine results in increased activity of [RELA protein binds to NFKB1 protein]] alpha-Tocopherol inhibits the reaction [Hexachlorocyclohexane results in increased activity of RELA protein]; alpha-Tocopherol inhibits the reaction [Triiodothyronine, Reverse results in increased activity of [NFKB1 protein binds to RELA protein]] |
CTD |
PMID:15025948 PMID:16135673 PMID:16882165 PMID:17936189 |
|
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
|
|
G |
Rps6 |
ribosomal protein S6 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [28-O-acetylbetulin-3-ylglucopyranoside results in decreased phosphorylation of RPS6 protein] |
CTD |
PMID:22343715 |
|
NCBI chr 5:105,197,821...105,200,681
Ensembl chr 5:105,197,857...105,200,148
|
|
G |
Rxra |
retinoid X receptor alpha |
multiple interactions |
ISO |
[Tretinoin co-treated with alpha-Tocopherol co-treated with Okadaic Acid] results in decreased phosphorylation of RXRA protein; [Tretinoin co-treated with alpha-Tocopherol] results in decreased phosphorylation of RXRA protein |
CTD |
PMID:15225641 |
|
NCBI chr 3:6,272,560...6,295,354
Ensembl chr 3:6,211,789...6,295,908
|
|
G |
Sele |
selectin E |
multiple interactions |
ISO |
[Ascorbic Acid co-treated with lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of SELE mRNA]; alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in increased expression of SELE protein]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of SELE mRNA] |
CTD |
PMID:12566129 PMID:25551565 |
|
NCBI chr13:82,355,234...82,365,323
Ensembl chr13:82,355,471...82,365,341
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
multiple interactions |
ISO |
[alpha-Tocopherol co-treated with Paraquat] results in increased expression of SLC7A11 mRNA; [alpha-Tocopherol co-treated with Paraquat] results in increased expression of SLC7A11 protein |
CTD |
PMID:24530478 |
|
NCBI chr 2:139,453,774...139,528,479
Ensembl chr 2:139,453,774...139,528,162
|
|
G |
Smad4 |
SMAD family member 4 |
multiple interactions |
ISO |
SMAD4 results in decreased susceptibility to [Fluorouracil co-treated with alpha-Tocopherol] |
CTD |
PMID:20562578 |
|
NCBI chr18:69,626,682...69,657,373
Ensembl chr18:69,627,757...69,671,199
|
|
G |
Snca |
synuclein alpha |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [Rotenone results in increased expression of SNCA protein] |
CTD |
PMID:16439141 |
|
NCBI chr 4:90,782,412...90,883,236
Ensembl chr 4:90,782,374...90,882,285
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions increases expression |
EXP ISO |
[alpha-Tocopherol co-treated with Ascorbic Acid] inhibits the reaction [arsenite results in increased expression of SOD1 protein]; alpha-Tocopherol inhibits the reaction [Malathion results in increased activity of SOD1 protein] alpha-Tocopherol results in increased expression of SOD1 mRNA; alpha-Tocopherol results in increased expression of SOD1 protein |
CTD |
PMID:19083475 PMID:20194575 PMID:21344382 PMID:22732938 |
|
NCBI chr11:30,363,282...30,368,858
Ensembl chr11:30,363,280...30,368,862
|
|
G |
Sod2 |
superoxide dismutase 2 |
decreases expression increases expression multiple interactions |
EXP |
alpha-Tocopherol results in decreased expression of SOD2 protein alpha-Tocopherol results in increased expression of SOD2 mRNA; alpha-Tocopherol results in increased expression of SOD2 protein [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of SOD2 mRNA; alpha-Tocopherol inhibits the reaction [Malathion results in increased activity of SOD2 protein]; alpha-Tocopherol inhibits the reaction [Triiodothyronine, Reverse results in increased expression of and results in increased activity of SOD2 protein] |
CTD |
PMID:16135673 PMID:18942769 PMID:20194575 PMID:22732938 PMID:23859036 |
|
NCBI chr 1:47,914,757...47,921,587
Ensembl chr 1:47,914,759...47,921,587
|
|
G |
Srsf2 |
serine and arginine rich splicing factor 2 |
decreases expression |
EXP |
alpha-Tocopherol deficiency results in decreased expression of SRSF2 protein |
CTD |
PMID:15247049 |
|
NCBI chr10:105,792,779...105,795,986
Ensembl chr10:105,792,779...105,795,958
|
|
G |
Star |
steroidogenic acute regulatory protein |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in decreased expression of STAR mRNA] |
CTD |
PMID:32134168 |
|
NCBI chr16:71,036,204...71,040,847
Ensembl chr16:71,036,204...71,040,847
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
increases expression |
EXP |
alpha-Tocopherol results in increased expression of STAT3 mRNA |
CTD |
PMID:16908007 |
|
NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
|
|
G |
Tert |
telomerase reverse transcriptase |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in decreased activity of TERT protein] |
CTD |
PMID:20112180 |
|
NCBI chr 1:32,250,876...32,275,330
Ensembl chr 1:32,251,714...32,272,476
|
|
G |
Tgfa |
transforming growth factor alpha |
decreases response to substance |
EXP |
alpha-Tocopherol results in decreased susceptibility to TGFA protein |
CTD |
PMID:7593635 |
|
NCBI chr 4:117,961,877...118,045,923
Ensembl chr 4:117,962,319...118,046,344
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions decreases expression |
EXP |
alpha-Tocopherol inhibits the reaction [TGFB1 protein results in increased abundance of Reactive Oxygen Species] alpha-Tocopherol results in decreased expression of TGFB1 mRNA |
CTD |
PMID:9608545 PMID:14732287 |
|
NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
|
|
G |
Th |
tyrosine hydroxylase |
multiple interactions |
EXP |
[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in decreased expression of TH protein; alpha-Tocopherol inhibits the reaction [Rotenone results in decreased expression of TH protein] |
CTD |
PMID:15790535 PMID:25891525 |
|
NCBI chr 1:216,073,034...216,080,287
Ensembl chr 1:216,073,031...216,080,287
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions affects expression decreases response to substance decreases expression |
ISO EXP |
[alpha-Tocopherol co-treated with gamma-Tocopherol] results in decreased expression of TNF protein; [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of CXCL8 protein]; [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of TNF protein]; [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of NFKBIA mRNA]; [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of SELE mRNA]; [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of TNF mRNA]; [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] promotes the reaction [TNF protein results in increased expression of and results in increased secretion of IL10 protein]; alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; alpha-Tocopherol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of TNF protein]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased abundance of Reactive Oxygen Species]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of CXCL8 protein]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of TNF protein]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of NFKBIA mRNA]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of SELE mRNA]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of TNF mRNA]; alpha-Tocopherol promotes the reaction [TNF protein promotes the reaction [Amiodarone results in increased activity of CASP3 protein]]; alpha-Tocopherol promotes the reaction [TNF protein promotes the reaction [Amiodarone results in increased activity of CASP7 protein]]; alpha-Tocopherol promotes the reaction [TNF protein results in increased expression of and results in increased secretion of IL10 protein] alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of TNF mRNA]; alpha-Tocopherol inhibits the reaction [Hexachlorocyclohexane results in increased expression of TNF mRNA]; alpha-Tocopherol inhibits the reaction [Hexachlorocyclohexane results in increased expression of TNF protein]; alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in increased expression of TNF protein]; alpha-Tocopherol inhibits the reaction [Triiodothyronine, Reverse results in increased secretion of TNF protein] alpha-Tocopherol affects the expression of TNF protein alpha-Tocopherol results in decreased susceptibility to TNF protein [alpha-Tocopherol co-treated with Nimodipine] inhibits the reaction [Dibutyl Phthalate results in increased expression of TNF protein]; alpha-Tocopherol inhibits the reaction [cumene hydroperoxide results in increased secretion of TNF protein]; alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of TNF protein]; alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; alpha-Tocopherol inhibits the reaction [Vitamin E deficiency results in increased expression of TNF mRNA] alpha-Tocopherol results in decreased expression of TNF protein |
CTD |
PMID:10588948 PMID:11805214 PMID:12195823 PMID:15025948 PMID:15630180 PMID:16135673 PMID:16750838 PMID:18191645 PMID:19135038 PMID:19135433 PMID:19735175 PMID:23042730 PMID:25551565 PMID:26332274 PMID:30776390 PMID:31712109 PMID:32134168 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [arsenite results in increased expression of TP53 mRNA]; alpha-Tocopherol inhibits the reaction [arsenite results in increased expression of TP53 protein] |
CTD |
PMID:12126965 |
|
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
G |
Txn1 |
thioredoxin 1 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with Ascorbic Acid] inhibits the reaction [arsenite results in increased expression of TXN1 protein] |
CTD |
PMID:21344382 |
|
NCBI chr 5:75,049,735...75,057,731
Ensembl chr 5:75,049,747...75,057,752
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of UGT1A1 mRNA] |
CTD |
PMID:22389237 |
|
NCBI chr 9:95,295,701...95,302,822
Ensembl chr 9:95,161,157...95,302,822
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in increased expression of VCAM1 protein]; alpha-Tocopherol inhibits the reaction [Vehicle Emissions results in increased expression of VCAM1 protein] |
CTD |
PMID:12566129 PMID:22313677 |
|
NCBI chr 2:219,071,193...219,090,931
Ensembl chr 2:219,071,193...219,097,619
|
|
G |
Xbp1 |
X-box binding protein 1 |
increases expression |
ISO |
alpha-Tocopherol analog results in increased expression of XBP1 mRNA |
CTD |
PMID:20686688 |
|
NCBI chr14:85,753,736...85,758,820
Ensembl chr14:85,753,760...85,758,145
|
|
G |
Xrcc6 |
X-ray repair cross complementing 6 |
multiple interactions |
EXP |
alpha-Tocopherol promotes the reaction [Acrylonitrile results in increased expression of XRCC6 mRNA] |
CTD |
PMID:26332274 |
|
NCBI chr 7:123,259,881...123,280,613
Ensembl chr 7:123,259,761...123,280,612
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases expression |
ISO |
tocotrienol, alpha results in increased expression of ABCB1 |
CTD |
PMID:15269186 |
|
NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Cyp3a62 |
cytochrome P450, family 3, subfamily a, polypeptide 62 |
multiple interactions increases expression |
ISO |
tocotrienol, alpha inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Testosterone]; tocotrienol, alpha inhibits the reaction [CYP3A4 protein results in increased oxidation of Lithocholic Acid] tocotrienol, alpha results in increased expression of CYP3A4 |
CTD |
PMID:15269186 PMID:31102695 |
|
NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
affects response to substance multiple interactions |
ISO |
CYP3A5 gene polymorphism affects the susceptibility to tocotrienol, alpha tocotrienol, alpha inhibits the reaction [CYP3A5 protein results in increased hydroxylation of Testosterone]; tocotrienol, alpha inhibits the reaction [CYP3A5 protein results in increased oxidation of Lithocholic Acid] |
CTD |
PMID:31102695 |
|
NCBI chr12:19,074,288...19,114,491
Ensembl chr12:19,074,583...19,114,399
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
multiple interactions |
ISO |
GSTM1 gene polymorphism affects the susceptibility to [Ascorbic Acid co-treated with tocotrienol, alpha] |
CTD |
PMID:15668500 |
|
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
|
|
G |
Ncor1 |
nuclear receptor co-repressor 1 |
multiple interactions |
ISO |
tocotrienol, alpha inhibits the reaction [NR1I2 protein binds to NCOR1 protein] |
CTD |
PMID:15269186 |
|
NCBI chr10:48,629,121...48,772,890
Ensembl chr10:48,629,121...48,772,890
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO |
tocotrienol, alpha binds to and results in increased activity of NR1I2 protein; tocotrienol, alpha inhibits the reaction [NR1I2 protein binds to NCOR1 protein] |
CTD |
PMID:15269186 |
|
NCBI chr11:65,022,100...65,058,546
Ensembl chr11:65,022,100...65,058,545
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
increases expression |
ISO |
tocotrienol, alpha results in increased expression of UGT1A1 |
CTD |
PMID:15269186 |
|
NCBI chr 9:95,295,701...95,302,822
Ensembl chr 9:95,161,157...95,302,822
|
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
EXP ISO |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of CASP3 protein] beta-Tocopherol affects the reaction [7-ketocholesterol results in increased activity of CASP3 protein]; beta-Tocopherol affects the reaction [cholest-5-en-3 beta,7 alpha-diol results in increased activity of CASP3 protein] |
CTD |
PMID:12450566 PMID:22389237 |
|
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of CYP1A1 mRNA] |
CTD |
PMID:22389237 |
|
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR1 protein] |
CTD |
PMID:22389237 |
|
NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR2 mRNA] |
CTD |
PMID:22389237 |
|
NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GCLM mRNA] |
CTD |
PMID:22389237 |
|
NCBI chr 2:225,827,504...225,847,876
Ensembl chr 2:225,827,504...225,847,874
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GSTM1 mRNA] |
CTD |
PMID:22389237 |
|
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of HMOX1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of HMOX1 protein] |
CTD |
PMID:22389237 |
|
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
|
|
G |
Nfe2l2 |
nuclear factor, erythroid 2-like 2 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NFE2L2 protein] |
CTD |
PMID:22389237 |
|
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NQO1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NQO1 protein] |
CTD |
PMID:22389237 |
|
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PCNA protein] |
CTD |
PMID:22389237 |
|
NCBI chr 3:124,880,698...124,884,570
Ensembl chr 3:124,880,698...124,884,570
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein] |
CTD |
PMID:22389237 |
|
NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PTGS2 protein] |
CTD |
PMID:22389237 |
|
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of UGT1A1 mRNA] |
CTD |
PMID:22389237 |
|
NCBI chr 9:95,295,701...95,302,822
Ensembl chr 9:95,161,157...95,302,822
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases expression |
ISO |
tocotrienol, beta results in increased expression of ABCB1 |
CTD |
PMID:15269186 |
|
NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Cyp3a62 |
cytochrome P450, family 3, subfamily a, polypeptide 62 |
increases expression |
ISO |
tocotrienol, beta results in increased expression of CYP3A4 |
CTD |
PMID:15269186 |
|
NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
|
|
G |
Ncor1 |
nuclear receptor co-repressor 1 |
multiple interactions |
ISO |
tocotrienol, beta inhibits the reaction [NR1I2 protein binds to NCOR1 protein] |
CTD |
PMID:15269186 |
|
NCBI chr10:48,629,121...48,772,890
Ensembl chr10:48,629,121...48,772,890
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO |
tocotrienol, beta binds to and results in increased activity of NR1I2 protein; tocotrienol, beta inhibits the reaction [NR1I2 protein binds to NCOR1 protein] |
CTD |
PMID:15269186 |
|
NCBI chr11:65,022,100...65,058,546
Ensembl chr11:65,022,100...65,058,545
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
increases expression |
ISO |
tocotrienol, beta results in increased expression of UGT1A1 |
CTD |
PMID:15269186 |
|
NCBI chr 9:95,295,701...95,302,822
Ensembl chr 9:95,161,157...95,302,822
|
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of CASP3 protein] |
CTD |
PMID:22389237 |
|
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Crabp2 |
cellular retinoic acid binding protein 2 |
multiple interactions |
ISO |
[Tretinoin co-treated with delta-tocopherol] results in increased expression of CRABP2 mRNA |
CTD |
PMID:15225641 |
|
NCBI chr 2:187,322,416...187,326,794
Ensembl chr 2:184,882,969...184,883,505
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of CYP1A1 mRNA] |
CTD |
PMID:22389237 |
|
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR1 protein] |
CTD |
PMID:22389237 |
|
NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR2 mRNA] |
CTD |
PMID:22389237 |
|
NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GCLM mRNA] |
CTD |
PMID:22389237 |
|
NCBI chr 2:225,827,504...225,847,876
Ensembl chr 2:225,827,504...225,847,874
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GSTM1 mRNA] |
CTD |
PMID:22389237 |
|
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of HMOX1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of HMOX1 protein] |
CTD |
PMID:22389237 |
|
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
|
|
G |
Nfe2l2 |
nuclear factor, erythroid 2-like 2 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NFE2L2 protein] |
CTD |
PMID:22389237 |
|
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NQO1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NQO1 protein] |
CTD |
PMID:22389237 |
|
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PCNA protein] |
CTD |
PMID:22389237 |
|
NCBI chr 3:124,880,698...124,884,570
Ensembl chr 3:124,880,698...124,884,570
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein] |
CTD |
PMID:22389237 |
|
NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PTGS2 protein] |
CTD |
PMID:22389237 |
|
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of UGT1A1 mRNA] |
CTD |
PMID:22389237 |
|
NCBI chr 9:95,295,701...95,302,822
Ensembl chr 9:95,161,157...95,302,822
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases expression |
ISO |
tocotrienol, delta results in increased expression of ABCB1 |
CTD |
PMID:15269186 |
|
NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
multiple interactions increases expression |
ISO |
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of ABCC1 mRNA] tocotrienol, delta results in increased expression of ABCC1 mRNA |
CTD |
PMID:22185406 |
|
NCBI chr10:549,537...672,235
Ensembl chr10:549,883...672,196
|
|
G |
Abcd2 |
ATP binding cassette subfamily D member 2 |
decreases expression |
ISO |
tocotrienol, delta results in decreased expression of ABCD2 mRNA |
CTD |
PMID:22185406 |
|
NCBI chr 7:132,294,564...132,343,169
Ensembl chr 7:132,294,562...132,343,169
|
|
G |
Actl6b |
actin-like 6B |
increases expression |
ISO |
tocotrienol, delta results in increased expression of ACTL6B mRNA |
CTD |
PMID:22185406 |
|
NCBI chr12:22,194,595...22,211,107
Ensembl chr12:22,194,618...22,211,080
|
|
G |
Atp2a2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
multiple interactions increases expression |
ISO |
tocotrienol, delta promotes the reaction [Lipopolysaccharides results in increased expression of ATP2A2 mRNA] tocotrienol, delta results in increased expression of ATP2A2 mRNA |
CTD |
PMID:22185406 |
|
NCBI chr12:39,553,903...39,603,326
Ensembl chr12:39,553,903...39,603,326
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
tocotrienol, delta results in decreased expression of CCND1 protein |
CTD |
PMID:21453743 |
|
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
|
|
G |
Ccnd2 |
cyclin D2 |
multiple interactions increases expression |
ISO |
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of CCND2 mRNA] tocotrienol, delta results in increased expression of CCND2 mRNA |
CTD |
PMID:22185406 |
|
NCBI chr 4:159,674,885...159,697,207
Ensembl chr 4:159,674,885...159,697,207
|
|
G |
Cd40 |
CD40 molecule |
multiple interactions increases expression |
ISO |
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of CD40 mRNA] tocotrienol, delta results in increased expression of CD40 mRNA |
CTD |
PMID:22185406 |
|
NCBI chr 3:161,519,789...161,534,943
Ensembl chr 3:161,519,743...161,534,704
|
|
G |
Cd69 |
Cd69 molecule |
multiple interactions increases expression |
ISO |
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of CD69 mRNA] tocotrienol, delta results in increased expression of CD69 mRNA |
CTD |
PMID:22185406 |
|
NCBI chr 4:163,041,147...163,049,065
Ensembl chr 4:163,041,141...163,049,084
|
|
G |
Cox7b2 |
cytochrome c oxidase subunit 7B2 |
multiple interactions decreases expression |
ISO |
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in decreased expression of COX7B2 mRNA] tocotrienol, delta results in decreased expression of COX7B2 mRNA |
CTD |
PMID:22185406 |
|
NCBI chr14:39,256,685...39,368,886
Ensembl chr14:39,368,530...39,368,769
|
|
G |
Crp |
C-reactive protein |
multiple interactions |
ISO |
[resveratrol co-treated with pterostilbene co-treated with Quercetin co-treated with tocotrienol, delta co-treated with Niacin] results in decreased expression of CRP protein |
CTD |
PMID:24319627 |
|
NCBI chr13:91,080,448...91,081,358
Ensembl chr13:91,054,974...91,093,713
|
|
G |
Ctnnb1 |
catenin beta 1 |
decreases expression |
ISO |
tocotrienol, delta results in decreased expression of CTNNB1 protein |
CTD |
PMID:21453743 |
|
NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372
|
|
G |
Cyp3a62 |
cytochrome P450, family 3, subfamily a, polypeptide 62 |
multiple interactions increases expression |
ISO |
tocotrienol, delta inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Testosterone]; tocotrienol, delta inhibits the reaction [CYP3A4 protein results in increased oxidation of Lithocholic Acid] tocotrienol, delta results in increased expression of CYP3A4 |
CTD |
PMID:15269186 PMID:31102695 |
|
NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
multiple interactions affects response to substance |
ISO |
tocotrienol, delta inhibits the reaction [CYP3A5 protein results in increased hydroxylation of Testosterone]; tocotrienol, delta inhibits the reaction [CYP3A5 protein results in increased oxidation of Lithocholic Acid] CYP3A5 gene polymorphism affects the susceptibility to tocotrienol, delta |
CTD |
PMID:31102695 |
|
NCBI chr12:19,074,288...19,114,491
Ensembl chr12:19,074,583...19,114,399
|
|
G |
Gimap1 |
GTPase, IMAP family member 1 |
multiple interactions decreases expression |
ISO |
tocotrienol, delta promotes the reaction [Lipopolysaccharides results in decreased expression of GIMAP1 mRNA] tocotrienol, delta results in decreased expression of GIMAP1 mRNA |
CTD |
PMID:22185406 |
|
NCBI chr 4:78,365,276...78,375,450
Ensembl chr 4:78,371,121...78,375,223
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
decreases expression multiple interactions |
ISO |
tocotrienol, delta results in decreased expression of ICAM1 mRNA tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 mRNA] |
CTD |
PMID:22185406 |
|
NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
|
|
G |
Ifnb1 |
interferon beta 1 |
multiple interactions |
ISO |
tocotrienol, delta inhibits the reaction [[IFNB1 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] |
CTD |
PMID:22185406 |
|
NCBI chr 5:106,865,192...106,865,746
Ensembl chr 5:106,865,192...106,865,746
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
tocotrienol, delta inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide] |
CTD |
PMID:22185406 |
|
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
|
|
G |
Ifngr1 |
interferon gamma receptor 1 |
decreases expression multiple interactions |
ISO |
tocotrienol, delta results in decreased expression of IFNGR1 mRNA tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in decreased expression of IFNGR1 mRNA] |
CTD |
PMID:22185406 |
|
NCBI chr 1:15,062,380...15,080,815
Ensembl chr 1:15,062,432...15,080,907
|
|
G |
Il12b |
interleukin 12B |
decreases expression multiple interactions |
ISO |
tocotrienol, delta results in decreased expression of IL12B mRNA tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of IL12B mRNA] |
CTD |
PMID:22185406 |
|
NCBI chr10:30,034,447...30,048,774
Ensembl chr10:30,038,709...30,048,085
|
|
G |
Il1a |
interleukin 1 alpha |
increases expression |
ISO |
tocotrienol, delta results in increased expression of IL1A mRNA |
CTD |
PMID:22185406 |
|
NCBI chr 3:121,824,712...121,836,122
Ensembl chr 3:121,825,412...121,836,086
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression |
ISO |
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] tocotrienol, delta results in increased expression of IL1B mRNA |
CTD |
PMID:22185406 |
|
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
increases expression multiple interactions |
ISO |
tocotrienol, delta results in increased expression of IL1RN mRNA tocotrienol, delta promotes the reaction [Lipopolysaccharides results in increased expression of IL1RN mRNA] |
CTD |
PMID:22185406 |
|
NCBI chr 3:1,449,778...1,468,624
Ensembl chr 3:1,452,644...1,468,614
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
ISO |
tocotrienol, delta results in increased expression of IL6 mRNA tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA] |
CTD |
PMID:22185406 |
|
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
decreases expression |
ISO |
tocotrienol, delta results in decreased expression of JUN protein |
CTD |
PMID:21453743 |
|
NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
decreases expression |
ISO |
tocotrienol, delta results in decreased expression of MMP7 protein |
CTD |
PMID:21453743 |
|
NCBI chr 8:5,893,253...5,900,965
Ensembl chr 8:5,893,249...5,901,049
|
|
G |
Ncor1 |
nuclear receptor co-repressor 1 |
multiple interactions |
ISO |
tocotrienol, delta inhibits the reaction [NR1I2 protein binds to NCOR1 protein] |
CTD |
PMID:15269186 |
|
NCBI chr10:48,629,121...48,772,890
Ensembl chr10:48,629,121...48,772,890
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
Lipopolysaccharides inhibits the reaction [tocotrienol, delta results in increased expression of NOS2]; tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] |
CTD |
PMID:21356098 PMID:22185406 |
|
NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO |
tocotrienol, delta binds to and results in increased activity of NR1I2 protein; tocotrienol, delta inhibits the reaction [NR1I2 protein binds to NCOR1 protein] |
CTD |
PMID:15269186 |
|
NCBI chr11:65,022,100...65,058,546
Ensembl chr11:65,022,100...65,058,545
|
|
G |
Phka2 |
phosphorylase kinase regulatory subunit alpha 2 |
multiple interactions increases expression |
ISO |
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in decreased expression of PHKA2 mRNA] tocotrienol, delta results in increased expression of PHKA2 mRNA |
CTD |
PMID:22185406 |
|
NCBI chr X:35,970,650...36,926,616
|
|
G |
Psmb2 |
proteasome 20S subunit beta 2 |
decreases expression |
ISO |
tocotrienol, delta results in decreased expression of PSMB2 mRNA |
CTD |
PMID:22185406 |
|
NCBI chr 5:144,702,004...144,734,220
Ensembl chr 5:144,701,949...144,734,257
|
|
G |
Ptbp2 |
polypyrimidine tract binding protein 2 |
multiple interactions increases expression |
ISO |
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in decreased expression of PTBP2 mRNA] tocotrienol, delta results in increased expression of PTBP2 mRNA |
CTD |
PMID:22185406 |
|
NCBI chr 2:223,261,444...223,323,075
Ensembl chr 2:223,262,852...223,322,585
|
|
G |
Rasgrp1 |
RAS guanyl releasing protein 1 |
multiple interactions increases expression |
ISO |
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of RASGRP1 mRNA] tocotrienol, delta results in increased expression of RASGRP1 mRNA |
CTD |
PMID:22185406 |
|
NCBI chr 3:108,984,029...109,044,420
Ensembl chr 3:108,984,029...109,044,420
|
|
G |
Rasgrp3 |
RAS guanyl releasing protein 3 |
decreases expression multiple interactions |
ISO |
tocotrienol, delta results in decreased expression of RASGRP3 mRNA tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in decreased expression of RASGRP3 mRNA] |
CTD |
PMID:22185406 |
|
NCBI chr 6:21,072,634...21,171,619
Ensembl chr 6:21,072,634...21,135,880
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
multiple interactions decreases expression |
ISO |
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of SOCS3 mRNA] tocotrienol, delta results in decreased expression of SOCS3 mRNA |
CTD |
PMID:22185406 |
|
NCBI chr10:106,973,863...106,976,969
Ensembl chr10:106,975,178...106,976,040
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions decreases expression |
ISO |
Lipopolysaccharides inhibits the reaction [tocotrienol, delta results in increased expression of TNF]; tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] tocotrienol, delta results in decreased expression of TNF mRNA |
CTD |
PMID:21356098 PMID:22185406 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Tnp1 |
transition protein 1 |
multiple interactions decreases expression |
ISO |
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in decreased expression of TNP1 mRNA] tocotrienol, delta results in decreased expression of TNP1 mRNA |
CTD |
PMID:22185406 |
|
NCBI chr 9:80,294,837...80,295,446
Ensembl chr 9:80,294,840...80,295,446
|
|
G |
Traf1 |
TNF receptor-associated factor 1 |
multiple interactions increases expression |
ISO |
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of TRAF1 mRNA] tocotrienol, delta results in increased expression of TRAF1 mRNA |
CTD |
PMID:22185406 |
|
NCBI chr 3:14,003,340...14,022,955
Ensembl chr 3:14,003,340...14,022,672
|
|
G |
Ube2d2 |
ubiquitin-conjugating enzyme E2D 2 |
multiple interactions decreases expression |
ISO |
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in decreased expression of UBE2D2A mRNA] tocotrienol, delta results in decreased expression of UBE2D2A mRNA |
CTD |
PMID:22185406 |
|
NCBI chr18:28,561,957...28,603,335
Ensembl chr18:28,594,892...28,603,335
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
increases expression |
ISO |
tocotrienol, delta results in increased expression of UGT1A1 |
CTD |
PMID:15269186 |
|
NCBI chr 9:95,295,701...95,302,822
Ensembl chr 9:95,161,157...95,302,822
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
multiple interactions decreases expression |
ISO |
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of VCAM1 mRNA] tocotrienol, delta results in decreased expression of VCAM1 mRNA |
CTD |
PMID:22185406 |
|
NCBI chr 2:219,071,193...219,090,931
Ensembl chr 2:219,071,193...219,097,619
|
|
G |
Wnt1 |
Wnt family member 1 |
decreases expression |
ISO |
tocotrienol, delta results in decreased expression of WNT1 protein |
CTD |
PMID:21453743 |
|
NCBI chr 7:140,464,999...140,469,046
Ensembl chr 7:140,464,999...140,469,046
|
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
decreases activity multiple interactions |
ISO |
Tocopherols results in decreased activity of ABCC1 protein Tocopherols inhibits the reaction [ABCC1 protein affects the export of Etoposide] |
CTD |
PMID:15617835 |
|
NCBI chr10:549,537...672,235
Ensembl chr10:549,883...672,196
|
|
G |
Alb |
albumin |
multiple interactions |
EXP |
gamma-Tocopherol inhibits the reaction [ALB protein results in increased expression of MUC5AC mRNA] |
CTD |
PMID:19389874 |
|
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
|
|
G |
App |
amyloid beta precursor protein |
decreases abundance multiple interactions |
EXP |
APP protein modified form results in decreased abundance of Tocopherols resveratrol inhibits the reaction [APP protein modified form results in decreased abundance of Tocopherols] |
CTD |
PMID:25654502 |
|
NCBI chr11:24,425,013...24,641,872
Ensembl chr11:24,425,005...24,641,858
|
|
G |
Ar |
androgen receptor |
decreases expression decreases activity |
ISO |
[Tocopherols results in decreased expression of AR protein] which results in decreased expression of KLK3 protein; Tocopherols results in decreased expression of AR mRNA; Tocopherols results in decreased expression of AR protein Tocopherols results in decreased activity of AR protein |
CTD |
PMID:12032296 PMID:16302272 |
|
NCBI chr X:67,656,253...67,828,998
Ensembl chr X:67,656,253...67,829,026
|
|
G |
Arf3 |
ADP-ribosylation factor 3 |
increases expression |
ISO |
Tocopherols results in increased expression of ARF3 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 7:140,412,463...140,438,751
Ensembl chr 7:140,398,199...140,437,467
|
|
G |
Aspm |
assembly factor for spindle microtubules |
increases expression |
ISO |
Tocopherols results in increased expression of ASPM mRNA |
CTD |
PMID:17056531 |
|
NCBI chr13:56,546,021...56,591,793
Ensembl chr13:56,546,021...56,591,793
|
|
G |
Atp1a2 |
ATPase Na+/K+ transporting subunit alpha 2 |
increases expression |
ISO |
Tocopherols results in increased expression of ATP1A2 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr13:90,651,682...90,676,629
Ensembl chr13:90,651,686...90,676,629
|
|
G |
Atp1b2 |
ATPase Na+/K+ transporting subunit beta 2 |
increases expression |
ISO |
Tocopherols results in increased expression of ATP1B2 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr10:56,205,622...56,211,879
Ensembl chr10:56,205,625...56,211,891
|
|
G |
Aurka |
aurora kinase A |
increases expression |
ISO |
Tocopherols results in increased expression of AURKA mRNA |
CTD |
PMID:17056531 |
|
NCBI chr 3:170,364,177...170,380,278
Ensembl chr 3:170,364,181...170,378,210
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases response to substance multiple interactions increases expression |
ISO |
BAX protein results in increased susceptibility to Tocopherols [Fluorouracil co-treated with gamma-Tocopherol] results in increased expression of BAX mRNA gamma-Tocopherol results in increased expression of BAX mRNA |
CTD |
PMID:16001965 PMID:31587439 |
|
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
increases expression multiple interactions decreases expression decreases response to substance |
ISO |
Tocopherols results in increased expression of BCL2 mRNA; Tocopherols results in increased expression of BCL2 protein [Fluorouracil co-treated with gamma-Tocopherol] results in decreased expression of BCL2 mRNA gamma-Tocopherol results in decreased expression of BCL2 mRNA BCL2 protein results in decreased susceptibility to Tocopherols |
CTD |
PMID:8970189 PMID:16001965 PMID:31587439 |
|
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases response to substance |
ISO |
BCL2L1 protein results in decreased susceptibility to Tocopherols |
CTD |
PMID:16001965 |
|
NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
increases expression |
ISO |
Tocopherols results in increased expression of BIRC5 mRNA |
CTD |
PMID:17056531 |
|
NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
|
|
G |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
increases expression |
ISO |
Tocopherols results in increased expression of CAMK2G mRNA |
CTD |
PMID:17654050 |
|
NCBI chr15:3,936,721...3,995,740
Ensembl chr15:3,936,786...3,995,915
|
|
G |
Casp3 |
caspase 3 |
increases activity multiple interactions |
ISO EXP |
gamma-Tocopherol results in increased activity of CASP3 protein [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of CASP3 protein] thermozymocidin inhibits the reaction [gamma-Tocopherol results in increased activity of CASP3 protein] |
CTD |
PMID:15596715 PMID:22389237 |
|
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Casp9 |
caspase 9 |
increases activity |
ISO |
gamma-Tocopherol results in increased activity of CASP9 protein |
CTD |
PMID:15596715 |
|
NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
|
|
G |
Cat |
catalase |
increases expression |
ISO |
gamma-Tocopherol results in increased expression of CAT protein |
CTD |
PMID:19115203 |
|
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
|
|
G |
Ccnb2 |
cyclin B2 |
increases expression |
ISO |
Tocopherols results in increased expression of CCNB2 mRNA |
CTD |
PMID:17056531 |
|
NCBI chr 8:76,847,972...76,861,165
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression multiple interactions |
ISO |
gamma-Tocopherol results in decreased expression of CCND1 mRNA; gamma-Tocopherol results in decreased expression of CCND1 protein; Tocopherols results in decreased expression of CCND1 protein [Fluorouracil co-treated with gamma-Tocopherol] results in decreased expression of CCND1 mRNA |
CTD |
PMID:12368234 PMID:12504091 PMID:31587439 |
|
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
|
|
G |
Ccnd3 |
cyclin D3 |
decreases expression |
ISO |
Tocopherols results in decreased expression of CCND3 protein |
CTD |
PMID:12504091 |
|
NCBI chr 9:15,404,816...15,410,905
Ensembl chr 9:15,404,822...15,410,943
|
|
G |
Ccne1 |
cyclin E1 |
decreases expression multiple interactions |
ISO |
gamma-Tocopherol results in decreased expression of CCNE1 mRNA; gamma-Tocopherol results in decreased expression of CCNE1 protein; Tocopherols results in decreased expression of CCNE1 mRNA; Tocopherols results in decreased expression of CCNE1 protein [Fluorouracil co-treated with gamma-Tocopherol] results in decreased expression of CCNE1 mRNA |
CTD |
PMID:12368234 PMID:12504091 PMID:31587439 |
|
NCBI chr 1:94,485,830...94,495,112
Ensembl chr 1:94,485,832...94,494,980
|
|
G |
Cdc6 |
cell division cycle 6 |
increases expression |
ISO |
Tocopherols results in increased expression of CDC6 mRNA |
CTD |
PMID:17056531 |
|
NCBI chr10:86,819,477...86,833,301
Ensembl chr10:86,819,472...86,833,402
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
increases expression |
ISO |
Tocopherols results in increased expression of CDK1 mRNA |
CTD |
PMID:17056531 |
|
NCBI chr20:20,576,341...20,591,510
Ensembl chr20:20,576,377...20,591,549
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression |
ISO |
Tocopherols results in decreased expression of CDK2 protein |
CTD |
PMID:12504091 |
|
NCBI chr 7:3,124,953...3,132,533
Ensembl chr 7:3,124,954...3,132,457
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
multiple interactions |
ISO |
Tocopherols results in decreased expression of and results in decreased activity of CDK4 protein |
CTD |
PMID:12504091 |
|
NCBI chr 7:70,345,971...70,352,689
Ensembl chr 7:70,349,863...70,352,418
|
|
G |
Cdk5r1 |
cyclin-dependent kinase 5 regulatory subunit 1 |
increases expression |
ISO |
Tocopherols results in increased expression of CDK5R1 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr10:67,862,054...67,863,255
Ensembl chr10:67,862,054...67,863,255
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
decreases expression |
ISO |
gamma-Tocopherol results in decreased expression of CDKN1A protein |
CTD |
PMID:12368234 |
|
NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
decreases expression |
ISO |
gamma-Tocopherol results in decreased expression of CDKN1B protein |
CTD |
PMID:12368234 |
|
NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
decreases expression |
ISO |
gamma-Tocopherol results in decreased expression of CDKN2A protein |
CTD |
PMID:12368234 |
|
NCBI chr 5:107,823,323...107,832,405
Ensembl chr 5:107,823,330...107,841,175
|
|
G |
Clec4e |
C-type lectin domain family 4, member E |
increases expression |
ISO |
Tocopherols results in increased expression of CLEC4E mRNA |
CTD |
PMID:17056531 |
|
NCBI chr 4:156,271,087...156,276,243
Ensembl chr 4:156,270,920...156,276,304
|
|
G |
Cplx1 |
complexin 1 |
increases expression |
ISO |
Tocopherols results in increased expression of CPLX1 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr14:2,194,895...2,226,610
Ensembl chr14:2,194,933...2,226,598
|
|
G |
Cplx2 |
complexin 2 |
increases expression |
ISO |
Tocopherols results in increased expression of CPLX2 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr17:10,756,871...10,828,811
Ensembl chr17:10,756,285...10,818,835
|
|
G |
Crabp2 |
cellular retinoic acid binding protein 2 |
multiple interactions |
ISO |
[Tretinoin co-treated with gamma-Tocopherol] results in increased expression of CRABP2 mRNA |
CTD |
PMID:15225641 |
|
NCBI chr 2:187,322,416...187,326,794
Ensembl chr 2:184,882,969...184,883,505
|
|
G |
Crp |
C-reactive protein |
multiple interactions |
ISO |
[alpha-Tocopherol co-treated with gamma-Tocopherol] results in decreased expression of CRP protein |
CTD |
PMID:18191645 |
|
NCBI chr13:91,080,448...91,081,358
Ensembl chr13:91,054,974...91,093,713
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
increases expression |
ISO |
Tocopherols results in increased expression of CSF1R mRNA |
CTD |
PMID:17056531 |
|
NCBI chr18:56,414,493...56,458,300
Ensembl chr18:56,414,488...56,458,300
|
|
G |
Csrp2 |
cysteine and glycine-rich protein 2 |
increases expression |
ISO |
Tocopherols results in increased expression of CSRP2 mRNA |
CTD |
PMID:17056531 |
|
NCBI chr 7:53,630,675...53,649,309
Ensembl chr 7:53,630,621...53,649,310
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of CYP1A1 mRNA] |
CTD |
PMID:22389237 |
|
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
|
|
G |
Dnajc5 |
DnaJ heat shock protein family (Hsp40) member C5 |
increases expression |
ISO |
Tocopherols results in increased expression of DNAJC5 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 3:177,012,714...177,047,787
Ensembl chr 3:177,013,604...177,043,902
|
|
G |
E2f1 |
E2F transcription factor 1 |
increases expression |
ISO |
Tocopherols results in increased expression of E2F1 protein |
CTD |
PMID:15883045 |
|
NCBI chr 3:150,062,895...150,073,721
Ensembl chr 3:150,047,826...150,073,721
|
|
G |
Egr1 |
early growth response 1 |
decreases activity |
ISO |
Tocopherols results in decreased activity of EGR1 protein |
CTD |
PMID:15878867 |
|
NCBI chr18:27,657,903...27,660,101
Ensembl chr18:27,657,628...27,661,429
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR1 protein] |
CTD |
PMID:22389237 |
|
NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR2 mRNA] |
CTD |
PMID:22389237 |
|
NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251
|
|
G |
Fcer1a |
Fc fragment of IgE receptor Ia |
increases expression |
ISO |
Tocopherols results in increased expression of FCER1A mRNA |
CTD |
PMID:17056531 |
|
NCBI chr13:91,727,253...91,737,106
Ensembl chr13:91,730,925...91,737,053
|
|
G |
Fes |
FES proto-oncogene, tyrosine kinase |
increases expression |
ISO |
Tocopherols results in increased expression of FES mRNA |
CTD |
PMID:17056531 |
|
NCBI chr 1:142,174,648...142,183,884
Ensembl chr 1:142,174,648...142,183,884
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
decreases expression |
ISO |
Tocopherols results in decreased expression of FGF1 mRNA |
CTD |
PMID:15878867 |
|
NCBI chr18:32,273,830...32,359,831
Ensembl chr18:32,273,770...32,359,824
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
decreases expression |
ISO |
Tocopherols results in decreased expression of FGF2 mRNA |
CTD |
PMID:15878867 |
|
NCBI chr 2:124,081,072...124,134,133
Ensembl chr 2:124,081,072...124,134,681
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
decreases expression |
ISO |
Tocopherols results in decreased expression of FGFR1 mRNA |
CTD |
PMID:15144885 |
|
NCBI chr16:71,265,390...71,319,046
Ensembl chr16:71,266,248...71,319,449
|
|
G |
Fkbp9 |
FKBP prolyl isomerase 9 |
increases expression |
ISO |
Tocopherols results in increased expression of FKBP9 mRNA |
CTD |
PMID:17056531 |
|
NCBI chr 4:87,167,514...87,234,198
Ensembl chr 4:87,167,514...87,234,197
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Tocopherols results in increased expression of FOS mRNA; Tocopherols results in increased expression of FOS protein |
CTD |
PMID:8970189 |
|
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GCLM mRNA] |
CTD |
PMID:22389237 |
|
NCBI chr 2:225,827,504...225,847,876
Ensembl chr 2:225,827,504...225,847,874
|
|
G |
Gria2 |
glutamate ionotropic receptor AMPA type subunit 2 |
increases expression |
ISO |
Tocopherols results in increased expression of GRIA2 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 2:179,584,302...179,704,629
Ensembl chr 2:179,584,308...179,704,629
|
|
G |
Grin1 |
glutamate ionotropic receptor NMDA type subunit 1 |
increases expression |
ISO |
Tocopherols results in increased expression of GRIN1 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 3:2,507,745...2,534,664
Ensembl chr 3:2,506,896...2,534,663
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
increases expression multiple interactions |
ISO EXP |
gamma-Tocopherol results in increased expression of GSTM1 mRNA; gamma-Tocopherol results in increased expression of GSTM1 protein [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GSTM1 mRNA] |
CTD |
PMID:19115203 PMID:22389237 |
|
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
|
|
G |
Gsto1 |
glutathione S-transferase omega 1 |
decreases activity |
ISO |
Tocopherols results in decreased activity of GSTO1 protein |
CTD |
PMID:16781109 |
|
NCBI chr 1:267,607,437...267,617,387
Ensembl chr 1:267,607,418...267,617,387
|
|
G |
Haspin |
histone H3 associated protein kinase |
increases expression |
ISO |
Tocopherols results in increased expression of HASPIN mRNA |
CTD |
PMID:17056531 |
|
NCBI chr10:59,695,403...59,698,398
Ensembl chr10:59,695,913...59,698,168
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions |
ISO EXP |
gamma-Tocopherol results in increased expression of HMOX1 protein [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of HMOX1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of HMOX1 protein] |
CTD |
PMID:19115203 PMID:22389237 |
|
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Tocopherols results in increased expression of JUN mRNA; Tocopherols results in increased expression of JUN protein |
CTD |
PMID:8970189 |
|
NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
|
|
G |
Kif20a |
kinesin family member 20A |
increases expression |
ISO |
Tocopherols results in increased expression of KIF20A mRNA |
CTD |
PMID:17056531 |
|
NCBI chr18:27,424,328...27,432,814
Ensembl chr18:27,424,328...27,432,814
|
|
G |
Kif4a |
kinesin family member 4A |
increases expression |
ISO |
Tocopherols results in increased expression of KIF4 mRNA |
CTD |
PMID:17056531 |
|
NCBI chr X:70,461,700...70,561,084
Ensembl chr X:70,461,718...70,561,189
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
decreases response to substance |
ISO |
MCL1 protein results in decreased susceptibility to Tocopherols |
CTD |
PMID:16001965 |
|
NCBI chr 2:197,786,212...197,788,992
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
multiple interactions |
EXP |
gamma-Tocopherol inhibits the reaction [ALB protein results in increased expression of MUC5AC mRNA] |
CTD |
PMID:19389874 |
|
NCBI chr 1:214,725,482...214,756,653
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
decreases expression decreases activity |
ISO |
Tocopherols results in decreased expression of MYC mRNA Tocopherols results in decreased activity of MYC protein |
CTD |
PMID:8970189 |
|
NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
|
|
G |
Napb |
NSF attachment protein beta |
increases expression |
ISO |
Tocopherols results in increased expression of NAPB mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 3:143,017,571...143,063,904
Ensembl chr 3:143,020,454...143,063,983
|
|
G |
Nfe2l2 |
nuclear factor, erythroid 2-like 2 |
increases expression multiple interactions |
ISO EXP |
gamma-Tocopherol results in increased expression of NFE2L2 mRNA; gamma-Tocopherol results in increased expression of NFE2L2 protein [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NFE2L2 protein] |
CTD |
PMID:19115203 PMID:22389237 |
|
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NQO1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NQO1 protein] |
CTD |
PMID:22389237 |
|
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
|
|
G |
Nsf |
N-ethylmaleimide sensitive factor, vesicle fusing ATPase |
increases expression |
ISO |
Tocopherols results in increased expression of NSF mRNA |
CTD |
PMID:17654050 |
|
NCBI chr10:91,879,608...91,986,242
Ensembl chr10:91,878,633...92,008,082
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions decreases expression |
EXP |
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PCNA protein] Tocopherols results in decreased expression of PCNA |
CTD |
PMID:17927505 PMID:22389237 |
|
NCBI chr 3:124,880,698...124,884,570
Ensembl chr 3:124,880,698...124,884,570
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
increases expression multiple interactions |
ISO EXP |
gamma-Tocopherol results in increased expression of PPARG mRNA; gamma-Tocopherol results in increased expression of PPARG protein [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein] |
CTD |
PMID:14521714 PMID:22389237 |
|
NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380
|
|
G |
Ppp3ca |
protein phosphatase 3 catalytic subunit alpha |
increases expression |
ISO |
Tocopherols results in increased expression of PPP3CA mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 2:241,909,332...242,186,861
Ensembl chr 2:241,909,832...242,184,854
|
|
G |
Prtn3 |
proteinase 3 |
increases expression |
ISO |
Tocopherols results in increased expression of PRTN3 mRNA |
CTD |
PMID:17056531 |
|
NCBI chr 7:12,643,712...12,646,951
Ensembl chr 7:12,643,516...12,646,960
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
decreases activity multiple interactions |
ISO EXP |
gamma-Tocopherol results in decreased activity of PTGS2 protein [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PTGS2 protein] |
CTD |
PMID:15225597 PMID:22389237 |
|
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
|
|
G |
Ptpro |
protein tyrosine phosphatase, receptor type, O |
increases expression |
ISO |
Tocopherols results in increased expression of PTPRO mRNA |
CTD |
PMID:17056531 |
|
NCBI chr 4:171,250,766...171,461,571
Ensembl chr 4:171,250,818...171,461,677
|
|
G |
Rab11b |
RAB11B, member RAS oncogene family |
increases expression |
ISO |
Tocopherols results in increased expression of RAB11B mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 7:18,598,991...18,612,132
Ensembl chr 7:18,598,880...18,612,147
|
|
G |
Rab3a |
RAB3A, member RAS oncogene family |
increases expression |
ISO |
Tocopherols results in increased expression of RAB3A mRNA |
CTD |
PMID:17654050 |
|
NCBI chr16:20,435,098...20,439,206
Ensembl chr16:20,435,101...20,439,206
|
|
G |
Rab6b |
RAB6B, member RAS oncogene family |
increases expression |
ISO |
Tocopherols results in increased expression of RAB6B mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 8:111,600,375...111,668,817
Ensembl chr 8:111,600,532...111,668,808
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
decreases phosphorylation |
ISO |
Tocopherols results in decreased phosphorylation of RB1 protein |
CTD |
PMID:12504091 |
|
NCBI chr15:55,081,582...55,209,060
Ensembl chr15:55,083,140...55,209,342
|
|
G |
Rrm1 |
ribonucleotide reductase catalytic subunit M1 |
increases expression |
ISO |
Tocopherols results in increased expression of RRM1 mRNA |
CTD |
PMID:17056531 |
|
NCBI chr 1:167,538,387...167,562,688
Ensembl chr 1:167,538,263...167,562,688
|
|
G |
Rrm2 |
ribonucleotide reductase regulatory subunit M2 |
increases expression |
ISO |
Tocopherols results in increased expression of RRM2 mRNA |
CTD |
PMID:17056531 |
|
NCBI chr 6:43,884,627...43,890,818
Ensembl chr 6:43,884,678...43,889,515
|
|
G |
Snca |
synuclein alpha |
increases expression |
ISO |
Tocopherols results in increased expression of SNCA mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 4:90,782,412...90,883,236
Ensembl chr 4:90,782,374...90,882,285
|
|
G |
Sncb |
synuclein, beta |
increases expression |
ISO |
Tocopherols results in increased expression of SNCB mRNA |
CTD |
PMID:17654050 |
|
NCBI chr17:10,384,472...10,392,776
Ensembl chr17:10,384,511...10,392,843
|
|
G |
Sod1 |
superoxide dismutase 1 |
increases expression |
ISO |
gamma-Tocopherol results in increased expression of SOD1 protein |
CTD |
PMID:19115203 |
|
NCBI chr11:30,363,282...30,368,858
Ensembl chr11:30,363,280...30,368,862
|
|
G |
Stx1a |
syntaxin 1A |
increases expression |
ISO |
Tocopherols results in increased expression of STX1A mRNA |
CTD |
PMID:17654050 |
|
NCBI chr12:24,682,050...24,710,002
Ensembl chr12:24,682,041...24,710,019
|
|
G |
Stxbp1 |
syntaxin binding protein 1 |
increases expression |
ISO |
Tocopherols results in increased expression of STXBP1 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 3:11,823,779...11,885,479
Ensembl chr 3:11,823,785...11,885,417
|
|
G |
Sv2a |
synaptic vesicle glycoprotein 2a |
increases expression |
ISO |
Tocopherols results in increased expression of SV2A mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 2:198,321,100...198,336,889
Ensembl chr 2:198,321,142...198,336,913
|
|
G |
Syn1 |
synapsin I |
increases expression |
ISO |
Tocopherols results in increased expression of SYN1 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr X:1,321,315...1,379,202
Ensembl chr X:1,321,315...1,379,198
|
|
G |
Syn2 |
synapsin II |
increases expression |
ISO |
Tocopherols results in increased expression of SYN2 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 4:147,037,179...147,195,096
Ensembl chr 4:147,037,179...147,195,096
|
|
G |
Syngr1 |
synaptogyrin 1 |
increases expression |
ISO |
Tocopherols results in increased expression of SYNGR1 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 7:121,311,008...121,334,437
Ensembl chr 7:121,311,024...121,334,437
|
|
G |
Syp |
synaptophysin |
increases expression |
ISO |
Tocopherols results in increased expression of SYP mRNA |
CTD |
PMID:17654050 |
|
NCBI chr X:15,694,699...15,709,244
Ensembl chr X:15,695,566...15,707,436
|
|
G |
Syt11 |
synaptotagmin 11 |
increases expression |
ISO |
Tocopherols results in increased expression of SYT11 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 2:188,112,301...188,138,180
Ensembl chr 2:188,112,286...188,138,177
|
|
G |
Syt13 |
synaptotagmin 13 |
increases expression |
ISO |
Tocopherols results in increased expression of SYT13 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 3:81,814,287...81,852,454
Ensembl chr 3:81,814,261...81,854,605
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO EXP |
[alpha-Tocopherol co-treated with gamma-Tocopherol] results in decreased expression of TNF protein Tocopherols inhibits the reaction [TNF protein results in decreased export of Potassium] |
CTD |
PMID:17337591 PMID:18191645 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Tnfaip2 |
TNF alpha induced protein 2 |
increases expression |
ISO |
Tocopherols results in increased expression of TNFAIP2 mRNA |
CTD |
PMID:17056531 |
|
NCBI chr 6:135,890,869...135,903,647
Ensembl chr 6:135,890,931...135,903,647
|
|
G |
Tp53 |
tumor protein p53 |
increases activity |
ISO |
Tocopherols results in increased activity of TP53 protein |
CTD |
PMID:15883045 |
|
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
G |
Ttc3 |
tetratricopeptide repeat domain 3 |
increases expression |
ISO |
Tocopherols results in increased expression of TTC3 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr11:34,598,324...34,739,986
Ensembl chr11:34,598,492...34,738,791
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
increases expression multiple interactions |
ISO EXP |
gamma-Tocopherol results in increased expression of UGT1A1 mRNA [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of UGT1A1 mRNA] |
CTD |
PMID:19115203 PMID:22389237 |
|
NCBI chr 9:95,295,701...95,302,822
Ensembl chr 9:95,161,157...95,302,822
|
|
G |
Vamp2 |
vesicle-associated membrane protein 2 |
increases expression |
ISO |
Tocopherols results in increased expression of VAMP2 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr10:55,675,171...55,679,405
Ensembl chr10:55,675,575...55,679,450
|
|
G |
Vdr |
vitamin D receptor |
increases expression |
ISO |
Tocopherols results in increased expression of VDR mRNA |
CTD |
PMID:12032296 |
|
NCBI chr 7:139,344,452...139,394,138
Ensembl chr 7:139,342,063...139,394,166
|
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
multiple interactions decreases activity |
ISO |
Tocopherols inhibits the reaction [ABCC1 protein affects the export of Etoposide] Tocopherols results in decreased activity of ABCC1 protein |
CTD |
PMID:15617835 |
|
NCBI chr10:549,537...672,235
Ensembl chr10:549,883...672,196
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions decreases abundance |
EXP |
resveratrol inhibits the reaction [APP protein modified form results in decreased abundance of Tocopherols] |
CTD |
PMID:25654502 |
|
NCBI chr11:24,425,013...24,641,872
Ensembl chr11:24,425,005...24,641,858
|
|
G |
Ar |
androgen receptor |
decreases activity decreases expression |
ISO |
Tocopherols results in decreased activity of AR protein [Tocopherols results in decreased expression of AR protein] which results in decreased expression of KLK3 protein; Tocopherols results in decreased expression of AR mRNA; Tocopherols results in decreased expression of AR protein |
CTD |
PMID:12032296 PMID:16302272 |
|
NCBI chr X:67,656,253...67,828,998
Ensembl chr X:67,656,253...67,829,026
|
|
G |
Arf3 |
ADP-ribosylation factor 3 |
increases expression |
ISO |
Tocopherols results in increased expression of ARF3 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 7:140,412,463...140,438,751
Ensembl chr 7:140,398,199...140,437,467
|
|
G |
Aspm |
assembly factor for spindle microtubules |
increases expression |
ISO |
Tocopherols results in increased expression of ASPM mRNA |
CTD |
PMID:17056531 |
|
NCBI chr13:56,546,021...56,591,793
Ensembl chr13:56,546,021...56,591,793
|
|
G |
Atp1a2 |
ATPase Na+/K+ transporting subunit alpha 2 |
increases expression |
ISO |
Tocopherols results in increased expression of ATP1A2 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr13:90,651,682...90,676,629
Ensembl chr13:90,651,686...90,676,629
|
|
G |
Atp1b2 |
ATPase Na+/K+ transporting subunit beta 2 |
increases expression |
ISO |
Tocopherols results in increased expression of ATP1B2 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr10:56,205,622...56,211,879
Ensembl chr10:56,205,625...56,211,891
|
|
G |
Aurka |
aurora kinase A |
increases expression |
ISO |
Tocopherols results in increased expression of AURKA mRNA |
CTD |
PMID:17056531 |
|
NCBI chr 3:170,364,177...170,380,278
Ensembl chr 3:170,364,181...170,378,210
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases response to substance |
ISO |
BAX protein results in increased susceptibility to Tocopherols |
CTD |
PMID:16001965 |
|
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases response to substance increases expression |
ISO |
BCL2 protein results in decreased susceptibility to Tocopherols Tocopherols results in increased expression of BCL2 mRNA; Tocopherols results in increased expression of BCL2 protein |
CTD |
PMID:8970189 PMID:16001965 |
|
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases response to substance |
ISO |
BCL2L1 protein results in decreased susceptibility to Tocopherols |
CTD |
PMID:16001965 |
|
NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
increases expression |
ISO |
Tocopherols results in increased expression of BIRC5 mRNA |
CTD |
PMID:17056531 |
|
NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
|
|
G |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
increases expression |
ISO |
Tocopherols results in increased expression of CAMK2G mRNA |
CTD |
PMID:17654050 |
|
NCBI chr15:3,936,721...3,995,740
Ensembl chr15:3,936,786...3,995,915
|
|
G |
Ccnb2 |
cyclin B2 |
increases expression |
ISO |
Tocopherols results in increased expression of CCNB2 mRNA |
CTD |
PMID:17056531 |
|
NCBI chr 8:76,847,972...76,861,165
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
Tocopherols results in decreased expression of CCND1 protein |
CTD |
PMID:12504091 |
|
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
|
|
G |
Ccnd3 |
cyclin D3 |
decreases expression |
ISO |
Tocopherols results in decreased expression of CCND3 protein |
CTD |
PMID:12504091 |
|
NCBI chr 9:15,404,816...15,410,905
Ensembl chr 9:15,404,822...15,410,943
|
|
G |
Ccne1 |
cyclin E1 |
decreases expression |
ISO |
Tocopherols results in decreased expression of CCNE1 mRNA; Tocopherols results in decreased expression of CCNE1 protein |
CTD |
PMID:12504091 |
|
NCBI chr 1:94,485,830...94,495,112
Ensembl chr 1:94,485,832...94,494,980
|
|
G |
Cdc6 |
cell division cycle 6 |
increases expression |
ISO |
Tocopherols results in increased expression of CDC6 mRNA |
CTD |
PMID:17056531 |
|
NCBI chr10:86,819,477...86,833,301
Ensembl chr10:86,819,472...86,833,402
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
increases expression |
ISO |
Tocopherols results in increased expression of CDK1 mRNA |
CTD |
PMID:17056531 |
|
NCBI chr20:20,576,341...20,591,510
Ensembl chr20:20,576,377...20,591,549
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression |
ISO |
Tocopherols results in decreased expression of CDK2 protein |
CTD |
PMID:12504091 |
|
NCBI chr 7:3,124,953...3,132,533
Ensembl chr 7:3,124,954...3,132,457
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
multiple interactions |
ISO |
Tocopherols results in decreased expression of and results in decreased activity of CDK4 protein |
CTD |
PMID:12504091 |
|
NCBI chr 7:70,345,971...70,352,689
Ensembl chr 7:70,349,863...70,352,418
|
|
G |
Cdk5r1 |
cyclin-dependent kinase 5 regulatory subunit 1 |
increases expression |
ISO |
Tocopherols results in increased expression of CDK5R1 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr10:67,862,054...67,863,255
Ensembl chr10:67,862,054...67,863,255
|
|
G |
Clec4e |
C-type lectin domain family 4, member E |
increases expression |
ISO |
Tocopherols results in increased expression of CLEC4E mRNA |
CTD |
PMID:17056531 |
|
NCBI chr 4:156,271,087...156,276,243
Ensembl chr 4:156,270,920...156,276,304
|
|
G |
Cplx1 |
complexin 1 |
increases expression |
ISO |
Tocopherols results in increased expression of CPLX1 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr14:2,194,895...2,226,610
Ensembl chr14:2,194,933...2,226,598
|
|
G |
Cplx2 |
complexin 2 |
increases expression |
ISO |
Tocopherols results in increased expression of CPLX2 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr17:10,756,871...10,828,811
Ensembl chr17:10,756,285...10,818,835
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
increases expression |
ISO |
Tocopherols results in increased expression of CSF1R mRNA |
CTD |
PMID:17056531 |
|
NCBI chr18:56,414,493...56,458,300
Ensembl chr18:56,414,488...56,458,300
|
|
G |
Csrp2 |
cysteine and glycine-rich protein 2 |
increases expression |
ISO |
Tocopherols results in increased expression of CSRP2 mRNA |
CTD |
PMID:17056531 |
|
NCBI chr 7:53,630,675...53,649,309
Ensembl chr 7:53,630,621...53,649,310
|
|
G |
Dnajc5 |
DnaJ heat shock protein family (Hsp40) member C5 |
increases expression |
ISO |
Tocopherols results in increased expression of DNAJC5 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 3:177,012,714...177,047,787
Ensembl chr 3:177,013,604...177,043,902
|
|
G |
E2f1 |
E2F transcription factor 1 |
increases expression |
ISO |
Tocopherols results in increased expression of E2F1 protein |
CTD |
PMID:15883045 |
|
NCBI chr 3:150,062,895...150,073,721
Ensembl chr 3:150,047,826...150,073,721
|
|
G |
Egr1 |
early growth response 1 |
decreases activity |
ISO |
Tocopherols results in decreased activity of EGR1 protein |
CTD |
PMID:15878867 |
|
NCBI chr18:27,657,903...27,660,101
Ensembl chr18:27,657,628...27,661,429
|
|
G |
Fcer1a |
Fc fragment of IgE receptor Ia |
increases expression |
ISO |
Tocopherols results in increased expression of FCER1A mRNA |
CTD |
PMID:17056531 |
|
NCBI chr13:91,727,253...91,737,106
Ensembl chr13:91,730,925...91,737,053
|
|
G |
Fes |
FES proto-oncogene, tyrosine kinase |
increases expression |
ISO |
Tocopherols results in increased expression of FES mRNA |
CTD |
PMID:17056531 |
|
NCBI chr 1:142,174,648...142,183,884
Ensembl chr 1:142,174,648...142,183,884
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
decreases expression |
ISO |
Tocopherols results in decreased expression of FGF1 mRNA |
CTD |
PMID:15878867 |
|
NCBI chr18:32,273,830...32,359,831
Ensembl chr18:32,273,770...32,359,824
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
decreases expression |
ISO |
Tocopherols results in decreased expression of FGF2 mRNA |
CTD |
PMID:15878867 |
|
NCBI chr 2:124,081,072...124,134,133
Ensembl chr 2:124,081,072...124,134,681
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
decreases expression |
ISO |
Tocopherols results in decreased expression of FGFR1 mRNA |
CTD |
PMID:15144885 |
|
NCBI chr16:71,265,390...71,319,046
Ensembl chr16:71,266,248...71,319,449
|
|
G |
Fkbp9 |
FKBP prolyl isomerase 9 |
increases expression |
ISO |
Tocopherols results in increased expression of FKBP9 mRNA |
CTD |
PMID:17056531 |
|
NCBI chr 4:87,167,514...87,234,198
Ensembl chr 4:87,167,514...87,234,197
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Tocopherols results in increased expression of FOS mRNA; Tocopherols results in increased expression of FOS protein |
CTD |
PMID:8970189 |
|
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
|
|
G |
Gria2 |
glutamate ionotropic receptor AMPA type subunit 2 |
increases expression |
ISO |
Tocopherols results in increased expression of GRIA2 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 2:179,584,302...179,704,629
Ensembl chr 2:179,584,308...179,704,629
|
|
G |
Grin1 |
glutamate ionotropic receptor NMDA type subunit 1 |
increases expression |
ISO |
Tocopherols results in increased expression of GRIN1 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 3:2,507,745...2,534,664
Ensembl chr 3:2,506,896...2,534,663
|
|
G |
Gsto1 |
glutathione S-transferase omega 1 |
decreases activity |
ISO |
Tocopherols results in decreased activity of GSTO1 protein |
CTD |
PMID:16781109 |
|
NCBI chr 1:267,607,437...267,617,387
Ensembl chr 1:267,607,418...267,617,387
|
|
G |
Haspin |
histone H3 associated protein kinase |
increases expression |
ISO |
Tocopherols results in increased expression of HASPIN mRNA |
CTD |
PMID:17056531 |
|
NCBI chr10:59,695,403...59,698,398
Ensembl chr10:59,695,913...59,698,168
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Tocopherols results in increased expression of JUN mRNA; Tocopherols results in increased expression of JUN protein |
CTD |
PMID:8970189 |
|
NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277
|
|
G |
Kif20a |
kinesin family member 20A |
increases expression |
ISO |
Tocopherols results in increased expression of KIF20A mRNA |
CTD |
PMID:17056531 |
|
NCBI chr18:27,424,328...27,432,814
Ensembl chr18:27,424,328...27,432,814
|
|
G |
Kif4a |
kinesin family member 4A |
increases expression |
ISO |
Tocopherols results in increased expression of KIF4 mRNA |
CTD |
PMID:17056531 |
|
NCBI chr X:70,461,700...70,561,084
Ensembl chr X:70,461,718...70,561,189
|
|
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
decreases response to substance |
ISO |
MCL1 protein results in decreased susceptibility to Tocopherols |
CTD |
PMID:16001965 |
|
NCBI chr 2:197,786,212...197,788,992
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
decreases activity decreases expression |
ISO |
Tocopherols results in decreased activity of MYC protein Tocopherols results in decreased expression of MYC mRNA |
CTD |
PMID:8970189 |
|
NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
|
|
G |
Napb |
NSF attachment protein beta |
increases expression |
ISO |
Tocopherols results in increased expression of NAPB mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 3:143,017,571...143,063,904
Ensembl chr 3:143,020,454...143,063,983
|
|
G |
Nsf |
N-ethylmaleimide sensitive factor, vesicle fusing ATPase |
increases expression |
ISO |
Tocopherols results in increased expression of NSF mRNA |
CTD |
PMID:17654050 |
|
NCBI chr10:91,879,608...91,986,242
Ensembl chr10:91,878,633...92,008,082
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression |
EXP |
Tocopherols results in decreased expression of PCNA |
CTD |
PMID:17927505 |
|
NCBI chr 3:124,880,698...124,884,570
Ensembl chr 3:124,880,698...124,884,570
|
|
G |
Ppp3ca |
protein phosphatase 3 catalytic subunit alpha |
increases expression |
ISO |
Tocopherols results in increased expression of PPP3CA mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 2:241,909,332...242,186,861
Ensembl chr 2:241,909,832...242,184,854
|
|
G |
Prtn3 |
proteinase 3 |
increases expression |
ISO |
Tocopherols results in increased expression of PRTN3 mRNA |
CTD |
PMID:17056531 |
|
NCBI chr 7:12,643,712...12,646,951
Ensembl chr 7:12,643,516...12,646,960
|
|
G |
Ptpro |
protein tyrosine phosphatase, receptor type, O |
increases expression |
ISO |
Tocopherols results in increased expression of PTPRO mRNA |
CTD |
PMID:17056531 |
|
NCBI chr 4:171,250,766...171,461,571
Ensembl chr 4:171,250,818...171,461,677
|
|
G |
Rab11b |
RAB11B, member RAS oncogene family |
increases expression |
ISO |
Tocopherols results in increased expression of RAB11B mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 7:18,598,991...18,612,132
Ensembl chr 7:18,598,880...18,612,147
|
|
G |
Rab3a |
RAB3A, member RAS oncogene family |
increases expression |
ISO |
Tocopherols results in increased expression of RAB3A mRNA |
CTD |
PMID:17654050 |
|
NCBI chr16:20,435,098...20,439,206
Ensembl chr16:20,435,101...20,439,206
|
|
G |
Rab6b |
RAB6B, member RAS oncogene family |
increases expression |
ISO |
Tocopherols results in increased expression of RAB6B mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 8:111,600,375...111,668,817
Ensembl chr 8:111,600,532...111,668,808
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
decreases phosphorylation |
ISO |
Tocopherols results in decreased phosphorylation of RB1 protein |
CTD |
PMID:12504091 |
|
NCBI chr15:55,081,582...55,209,060
Ensembl chr15:55,083,140...55,209,342
|
|
G |
Rrm1 |
ribonucleotide reductase catalytic subunit M1 |
increases expression |
ISO |
Tocopherols results in increased expression of RRM1 mRNA |
CTD |
PMID:17056531 |
|
NCBI chr 1:167,538,387...167,562,688
Ensembl chr 1:167,538,263...167,562,688
|
|
G |
Rrm2 |
ribonucleotide reductase regulatory subunit M2 |
increases expression |
ISO |
Tocopherols results in increased expression of RRM2 mRNA |
CTD |
PMID:17056531 |
|
NCBI chr 6:43,884,627...43,890,818
Ensembl chr 6:43,884,678...43,889,515
|
|
G |
Snca |
synuclein alpha |
increases expression |
ISO |
Tocopherols results in increased expression of SNCA mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 4:90,782,412...90,883,236
Ensembl chr 4:90,782,374...90,882,285
|
|
G |
Sncb |
synuclein, beta |
increases expression |
ISO |
Tocopherols results in increased expression of SNCB mRNA |
CTD |
PMID:17654050 |
|
NCBI chr17:10,384,472...10,392,776
Ensembl chr17:10,384,511...10,392,843
|
|
G |
Stx1a |
syntaxin 1A |
increases expression |
ISO |
Tocopherols results in increased expression of STX1A mRNA |
CTD |
PMID:17654050 |
|
NCBI chr12:24,682,050...24,710,002
Ensembl chr12:24,682,041...24,710,019
|
|
G |
Stxbp1 |
syntaxin binding protein 1 |
increases expression |
ISO |
Tocopherols results in increased expression of STXBP1 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 3:11,823,779...11,885,479
Ensembl chr 3:11,823,785...11,885,417
|
|
G |
Sv2a |
synaptic vesicle glycoprotein 2a |
increases expression |
ISO |
Tocopherols results in increased expression of SV2A mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 2:198,321,100...198,336,889
Ensembl chr 2:198,321,142...198,336,913
|
|
G |
Syn1 |
synapsin I |
increases expression |
ISO |
Tocopherols results in increased expression of SYN1 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr X:1,321,315...1,379,202
Ensembl chr X:1,321,315...1,379,198
|
|
G |
Syn2 |
synapsin II |
increases expression |
ISO |
Tocopherols results in increased expression of SYN2 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 4:147,037,179...147,195,096
Ensembl chr 4:147,037,179...147,195,096
|
|
G |
Syngr1 |
synaptogyrin 1 |
increases expression |
ISO |
Tocopherols results in increased expression of SYNGR1 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 7:121,311,008...121,334,437
Ensembl chr 7:121,311,024...121,334,437
|
|
G |
Syp |
synaptophysin |
increases expression |
ISO |
Tocopherols results in increased expression of SYP mRNA |
CTD |
PMID:17654050 |
|
NCBI chr X:15,694,699...15,709,244
Ensembl chr X:15,695,566...15,707,436
|
|
G |
Syt11 |
synaptotagmin 11 |
increases expression |
ISO |
Tocopherols results in increased expression of SYT11 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 2:188,112,301...188,138,180
Ensembl chr 2:188,112,286...188,138,177
|
|
G |
Syt13 |
synaptotagmin 13 |
increases expression |
ISO |
Tocopherols results in increased expression of SYT13 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr 3:81,814,287...81,852,454
Ensembl chr 3:81,814,261...81,854,605
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP |
Tocopherols inhibits the reaction [TNF protein results in decreased export of Potassium] |
CTD |
PMID:17337591 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Tnfaip2 |
TNF alpha induced protein 2 |
increases expression |
ISO |
Tocopherols results in increased expression of TNFAIP2 mRNA |
CTD |
PMID:17056531 |
|
NCBI chr 6:135,890,869...135,903,647
Ensembl chr 6:135,890,931...135,903,647
|
|
G |
Tp53 |
tumor protein p53 |
increases activity |
ISO |
Tocopherols results in increased activity of TP53 protein |
CTD |
PMID:15883045 |
|
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
G |
Ttc3 |
tetratricopeptide repeat domain 3 |
increases expression |
ISO |
Tocopherols results in increased expression of TTC3 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr11:34,598,324...34,739,986
Ensembl chr11:34,598,492...34,738,791
|
|
G |
Vamp2 |
vesicle-associated membrane protein 2 |
increases expression |
ISO |
Tocopherols results in increased expression of VAMP2 mRNA |
CTD |
PMID:17654050 |
|
NCBI chr10:55,675,171...55,679,405
Ensembl chr10:55,675,575...55,679,450
|
|
G |
Vdr |
vitamin D receptor |
increases expression |
ISO |
Tocopherols results in increased expression of VDR mRNA |
CTD |
PMID:12032296 |
|
NCBI chr 7:139,344,452...139,394,138
Ensembl chr 7:139,342,063...139,394,166
|
|
|
G |
Aamp |
angio-associated, migratory cell protein |
increases expression |
ISO |
Vitamin E results in increased expression of AAMP mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:81,560,836...81,566,642
Ensembl chr 9:81,560,842...81,566,642
|
|
G |
Aass |
aminoadipate-semialdehyde synthase |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of AASS mRNA Vitamin E results in decreased expression of AASS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:50,152,005...50,208,935
Ensembl chr 4:50,152,452...50,200,328
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [nickel chloride results in increased expression of ABCB1 protein] |
CTD |
PMID:24448832 |
|
NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
multiple interactions |
EXP |
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of ABCC2 mRNA |
CTD |
PMID:11444866 |
|
NCBI chr 1:263,554,426...263,612,556
Ensembl chr 1:263,554,453...263,613,252
|
|
G |
Abcd1 |
ATP binding cassette subfamily D member 1 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in decreased expression of ABCD1 mRNA] |
CTD |
PMID:29065513 |
|
NCBI chr X:157,073,860...157,095,652
Ensembl chr X:157,072,736...157,095,274
|
|
G |
Abcd3 |
ATP binding cassette subfamily D member 3 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in decreased expression of ABCD3 mRNA] |
CTD |
PMID:29065513 |
|
NCBI chr 2:225,335,708...225,389,120
Ensembl chr 2:225,335,718...225,389,120
|
|
G |
Abhd14a |
abhydrolase domain containing 14A |
decreases expression |
ISO |
Vitamin E results in decreased expression of ABHD14A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:115,141,575...115,151,222
Ensembl chr 8:115,141,539...115,149,527
|
|
G |
Abhd2 |
abhydrolase domain containing 2, acylglycerol lipase |
decreases expression increases expression |
ISO |
Vitamin E results in decreased expression of ABHD2 mRNA Vitamin E results in increased expression of ABHD2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:140,998,240...141,087,405
Ensembl chr 1:140,998,240...141,087,405
|
|
G |
Abhd4 |
abhydrolase domain containing 4, N-acyl phospholipase B |
increases expression |
ISO |
Vitamin E results in increased expression of ABHD4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:32,888,233...32,906,861
Ensembl chr15:32,894,938...32,906,850
|
|
G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
increases expression |
ISO |
Vitamin E results in increased expression of ACAA2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:70,733,872...70,762,395
Ensembl chr18:70,733,872...70,762,395
|
|
G |
Acads |
acyl-CoA dehydrogenase short chain |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of ACADS mRNA Vitamin E results in increased expression of ACADS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:47,254,503...47,263,747
Ensembl chr12:47,254,484...47,263,747
|
|
G |
Acat1 |
acetyl-CoA acetyltransferase 1 |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [iron(II)-ascorbic acid complex results in decreased activity of ACAT1 protein] |
CTD |
PMID:10656290 |
|
NCBI chr 8:58,166,990...58,195,884
Ensembl chr 8:58,166,990...58,195,884
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions |
ISO EXP |
[Resveratrol co-treated with Ascorbic Acid co-treated with Thioctic Acid co-treated with Vitamin E] results in increased activity of ACHE protein; Hexachlorocyclohexane inhibits the reaction [[Resveratrol co-treated with Ascorbic Acid co-treated with Thioctic Acid co-treated with Vitamin E] results in increased activity of ACHE protein] [Zinc co-treated with Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [sodium arsenite results in increased activity of ACHE protein]; alpha-Tocopherol inhibits the reaction [Streptozocin results in increased activity of ACHE protein]; Vitamin E inhibits the reaction [Scopolamine results in decreased activity of ACHE protein] |
CTD |
PMID:11814146 PMID:19464315 PMID:20663516 PMID:23619517 |
|
NCBI chr12:22,472,358...22,477,052
Ensembl chr12:22,472,358...22,478,753
|
|
G |
Aco2 |
aconitase 2 |
increases expression |
ISO |
Vitamin E results in increased expression of ACO2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:123,102,493...123,145,608
Ensembl chr 7:123,102,468...123,145,635
|
|
G |
Acot2 |
acyl-CoA thioesterase 2 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ACOT2 mRNA Vitamin E results in increased expression of ACOT2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:107,460,596...107,468,324
Ensembl chr 6:107,460,668...107,467,487
|
|
G |
Acp1 |
acid phosphatase 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ACP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:49,836,064...49,851,714
Ensembl chr 6:49,836,075...49,851,714
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
decreases expression |
ISO |
Vitamin E results in decreased expression of ACTA2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:252,537,614...252,550,394
Ensembl chr 1:252,537,615...252,550,394
|
|
G |
Actb |
actin, beta |
increases expression |
ISO |
Vitamin E results in increased expression of ACTB mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:13,715,843...13,718,813
Ensembl chr12:13,715,843...13,718,841
|
|
G |
Actn4 |
actinin alpha 4 |
increases expression |
ISO |
Vitamin E results in increased expression of ACTN4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:87,078,012...87,147,347
Ensembl chr 1:87,078,020...87,147,333
|
|
G |
Actr1a |
actin related protein 1A |
increases expression |
ISO |
Vitamin E results in increased expression of ACTR1A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:266,123,864...266,142,621
Ensembl chr 1:266,123,870...266,142,538
|
|
G |
Actr1b |
actin related protein 1B |
increases expression |
ISO |
Vitamin E results in increased expression of ACTR1B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:43,267,053...43,276,717
Ensembl chr 9:43,267,057...43,276,685
|
|
G |
Acvr2a |
activin A receptor type 2A |
decreases expression |
ISO |
Vitamin E results in decreased expression of ACVR2A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:32,947,901...33,034,598
Ensembl chr 3:32,947,378...33,034,282
|
|
G |
Acvrl1 |
activin A receptor like type 1 |
increases expression |
EXP |
alpha-Tocopherol results in increased expression of ACVRL1 mRNA |
CTD |
PMID:16908007 |
|
NCBI chr 7:142,769,942...142,787,336
Ensembl chr 7:142,776,252...142,787,335
|
|
G |
Adam17 |
ADAM metallopeptidase domain 17 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ADAM17 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:43,400,525...43,448,280
Ensembl chr 6:43,400,528...43,448,280
|
|
G |
Adamts5 |
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ADAMTS5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:25,411,174...25,456,639
Ensembl chr11:25,410,975...25,456,836
|
|
G |
Adap1 |
ArfGAP with dual PH domains 1 |
increases expression |
ISO |
Vitamin E results in increased expression of ADAP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:17,416,327...17,468,212
Ensembl chr12:17,416,327...17,468,212
|
|
G |
Adarb1 |
adenosine deaminase, RNA-specific, B1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ADARB1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:11,972,352...12,101,022
Ensembl chr20:11,972,381...12,101,047
|
|
G |
Adcy2 |
adenylate cyclase 2 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ADCY2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:37,043,071...37,698,390
Ensembl chr 1:37,507,276...37,698,390
|
|
G |
Adcy6 |
adenylate cyclase 6 |
increases expression |
ISO |
Vitamin E results in increased expression of ADCY6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:140,270,678...140,291,722
Ensembl chr 7:140,270,692...140,291,620
|
|
G |
Add1 |
adducin 1 |
increases expression |
ISO |
Vitamin E results in increased expression of ADD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:81,367,466...81,426,610
Ensembl chr14:81,367,468...81,426,496
|
|
G |
Add3 |
adducin 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ADD3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:273,854,195...273,961,982
Ensembl chr 1:273,854,248...273,961,982
|
|
G |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
increases expression |
ISO |
Vitamin E results in increased expression of ADGRB1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:115,766,484...115,828,514
|
|
G |
Adh7 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
decreases expression |
ISO |
Vitamin E results in decreased expression of ADH7 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:243,500,540...243,516,865
Ensembl chr 2:243,502,073...243,516,532
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ mRNA]; Vitamin E inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ protein] |
CTD |
PMID:20404018 |
|
NCBI chr11:81,330,845...81,344,488
Ensembl chr11:81,330,293...81,344,488
|
|
G |
Adra2c |
adrenoceptor alpha 2C |
increases expression |
ISO |
Vitamin E results in increased expression of ADRA2C mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:80,730,307...80,732,010
Ensembl chr14:80,730,307...80,732,010
|
|
G |
Adrm1 |
adhesion regulating molecule 1 |
increases expression |
ISO |
Vitamin E results in increased expression of ADRM1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:175,548,181...175,552,943
Ensembl chr 3:175,548,174...175,552,947
|
|
G |
Aebp1 |
AE binding protein 1 |
increases expression |
ISO |
Vitamin E results in increased expression of AEBP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:86,101,253...86,111,323
Ensembl chr14:86,101,277...86,111,306
|
|
G |
Aen |
apoptosis enhancing nuclease |
increases expression |
ISO |
Vitamin E results in increased expression of AEN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:140,584,328...140,593,749
Ensembl chr 1:140,584,380...140,593,745
|
|
G |
Agpat2 |
1-acylglycerol-3-phosphate O-acyltransferase 2 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of AGPAT2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:4,044,741...4,055,384
Ensembl chr 3:4,044,542...4,055,806
|
|
G |
Agrn |
agrin |
decreases expression |
ISO |
Vitamin E results in decreased expression of AGRN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:173,589,910...173,622,813
Ensembl chr 5:173,589,819...173,622,645
|
|
G |
Agt |
angiotensinogen |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [AGT protein results in increased expression of PSMC6 protein]; alpha-Tocopherol inhibits the reaction [AGT protein results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:17532611 |
|
NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
|
|
G |
Agtpbp1 |
ATP/GTP binding protein 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of AGTPBP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:5,510,009...5,614,416
Ensembl chr17:5,511,385...5,614,435
|
|
G |
Ahnak |
AHNAK nucleoprotein |
increases expression |
ISO |
Vitamin E results in increased expression of AHNAK mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:225,184,883...225,429,638
Ensembl chr 1:225,184,939...225,215,015
|
|
G |
Ahnak2 |
AHNAK nucleoprotein 2 |
increases expression |
ISO |
Vitamin E results in increased expression of AHNAK2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:137,335,273...137,380,219
|
|
G |
Ahr |
aryl hydrocarbon receptor |
decreases expression |
ISO |
Vitamin E results in decreased expression of AHR mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:54,963,990...55,001,806
Ensembl chr 6:54,963,990...55,001,464
|
|
G |
Aimp1 |
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of AIMP1 mRNA Vitamin E results in decreased expression of AIMP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:237,727,782...237,751,327
Ensembl chr 2:237,727,764...237,751,378
|
|
G |
Ak1 |
adenylate kinase 1 |
increases expression |
ISO |
Vitamin E results in increased expression of AK1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:11,652,143...11,659,135
|
|
G |
Ak3 |
adenylate kinase 3 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of AK3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:247,144,486...247,169,690
Ensembl chr 1:247,144,491...247,169,693
|
|
G |
Akap13 |
A-kinase anchoring protein 13 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of AKAP13 mRNA Vitamin E results in decreased expression of AKAP13 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:137,089,558...137,315,272
Ensembl chr 1:137,014,272...137,315,272
|
|
G |
Akap2 |
A-kinase anchoring protein 2 |
increases expression decreases expression |
ISO |
Vitamin E results in increased expression of PALM2AKAP2 mRNA Vitamin E results in decreased expression of PALM2AKAP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:74,874,245...74,985,789
Ensembl chr 5:74,874,306...74,982,401
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B |
increases expression |
EXP ISO |
alpha-Tocopherol results in increased expression of AKR1B1 mRNA Vitamin E results in increased expression of AKR1B1 mRNA |
CTD |
PMID:16908007 PMID:19244175 |
|
NCBI chr 4:61,706,866...61,720,959
Ensembl chr 4:61,706,864...61,720,956
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
increases expression |
ISO |
Vitamin E results in increased expression of AKR1C2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:69,388,337...69,435,160
Ensembl chr17:69,388,335...69,404,341
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions increases expression |
ISO EXP |
alpha-Tocopherol inhibits the reaction [28-O-acetylbetulin-3-ylglucopyranoside results in decreased phosphorylation of AKT1 protein] [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in decreased phosphorylation of AKT1 protein]; alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in decreased phosphorylation of and results in decreased activity of AKT1 protein] Vitamin E results in increased expression of AKT1 mRNA |
CTD |
PMID:19244175 PMID:19351882 PMID:21911000 PMID:22343715 |
|
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
|
|
G |
Alad |
aminolevulinate dehydratase |
multiple interactions |
ISO EXP |
alpha-Tocopherol inhibits the reaction [[Streptozocin results in increased abundance of Blood Glucose] which results in decreased expression of ALAD protein] Vitamin E inhibits the reaction [lead acetate results in decreased activity of ALAD protein] |
CTD |
PMID:2604901 PMID:7728901 |
|
NCBI chr 5:78,368,867...78,379,206
Ensembl chr 5:78,368,867...78,379,346
|
|
G |
Alas1 |
5'-aminolevulinate synthase 1 |
multiple interactions |
EXP |
alpha-Tocopherol inhibits the reaction [Paraquat results in increased activity of ALAS1 protein] |
CTD |
PMID:12180188 |
|
NCBI chr 8:114,927,704...114,941,038
Ensembl chr 8:114,927,722...114,940,177
|
|
G |
Alb |
albumin |
multiple interactions |
ISO EXP |
Vitamin E inhibits the reaction [Ethanol results in decreased expression of ALB protein] [Quercetin co-treated with Vitamin E] inhibits the reaction [Cyclosporine results in decreased expression of ALB protein]; alpha-Tocopherol inhibits the reaction [beryllium nitrate results in decreased expression of ALB protein]; sodium-4,5-dihydroxy-1,3-benzene disulfonate promotes the reaction [alpha-Tocopherol inhibits the reaction [beryllium nitrate results in decreased expression of ALB protein]]; Vitamin E inhibits the reaction [Cyclosporine results in decreased expression of ALB protein] Vitamin E inhibits the reaction [Oleic Acid results in decreased secretion of ALB protein] |
CTD |
PMID:17429802 PMID:17927767 PMID:21086752 PMID:23348005 |
|
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
|
|
G |
Aldh6a1 |
aldehyde dehydrogenase 6 family, member A1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ALDH6A1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:108,146,552...108,167,185
Ensembl chr 6:108,146,582...108,167,185
|
|
G |
Aldoa |
aldolase, fructose-bisphosphate A |
increases expression |
ISO |
Vitamin E results in increased expression of ALDOA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:198,228,387...198,233,988
Ensembl chr 1:198,228,387...198,233,588
|
|
G |
Alg3 |
ALG3, alpha-1,3- mannosyltransferase |
increases expression |
ISO |
Vitamin E results in increased expression of ALG3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:83,985,484...83,991,706
Ensembl chr11:83,986,230...83,991,706
|
|
G |
Alg9 |
ALG9, alpha-1,2-mannosyltransferase |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ALG9 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:55,202,140...55,265,478
Ensembl chr 8:55,202,725...55,265,478
|
|
G |
Alkbh1 |
alkB homolog 1, histone H2A dioxygenase |
decreases expression |
ISO |
Vitamin E results in decreased expression of ALKBH1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:111,456,096...111,476,829
Ensembl chr 6:111,456,187...111,477,090
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
decreases activity multiple interactions |
ISO EXP |
Vitamin E results in decreased activity of ALOX5 protein [Vitamin E co-treated with Selenium] results in decreased expression of ALOX5 mRNA; [Vitamin E co-treated with Selenium] results in decreased expression of ALOX5 protein |
CTD |
PMID:11325678 PMID:12200813 PMID:22223226 |
|
NCBI chr 4:148,398,004...148,446,308
Ensembl chr 4:148,398,892...148,446,303
|
|
G |
Ambra1 |
autophagy and beclin 1 regulator 1 |
increases expression |
ISO |
Vitamin E results in increased expression of AMBRA1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:80,634,470...80,830,068
Ensembl chr 3:80,634,470...80,830,068
|
|
G |
Anapc15 |
anaphase promoting complex subunit 15 |
increases expression |
ISO |
Vitamin E results in increased expression of ANAPC15 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:166,981,738...166,985,363
Ensembl chr 1:166,983,175...166,985,054
|
|
G |
Andpro |
androgen regulated protein |
decreases expression |
EXP |
Vitamin E results in decreased expression of ANDPRO mRNA |
CTD |
PMID:15084515 |
|
NCBI chr 3:143,893,005...143,899,609
Ensembl chr 3:143,893,006...143,899,370
|
|
G |
Angpt1 |
angiopoietin 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ANGPT1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:81,338,327...81,592,459
Ensembl chr 7:81,342,280...81,592,206
|
|
G |
Ank3 |
ankyrin 3 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of ANK3 mRNA Vitamin E results in decreased expression of ANK3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:19,948,767...20,480,628
Ensembl chr20:20,105,047...20,480,623
|
|
G |
Ankrd12 |
ankyrin repeat domain 12 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ANKRD12 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:113,605,683...113,682,482
Ensembl chr 9:113,605,657...113,682,482
|
|
G |
Ano6 |
anoctamin 6 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [Ozone results in increased expression of ANO6 mRNA] |
CTD |
PMID:27886375 |
|
NCBI chr 7:137,142,063...137,335,208
Ensembl chr 7:137,142,170...137,335,208
|
|
G |
Anp32b |
acidic nuclear phosphoprotein 32 family member B |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of ANP32B mRNA Vitamin E results in decreased expression of ANP32B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:62,070,709...62,094,633
Ensembl chr 5:62,071,346...62,094,633
|
|
G |
Anxa6 |
annexin A6 |
increases expression |
ISO |
Vitamin E results in increased expression of ANXA6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:40,320,581...40,375,605
Ensembl chr10:40,320,581...40,375,605
|
|
G |
Ap1m2 |
adaptor related protein complex 1 subunit mu 2 |
increases expression |
ISO |
Vitamin E results in increased expression of AP1M2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:22,318,941...22,336,827
Ensembl chr 8:22,319,331...22,336,794
|
|
G |
Ap2a2 |
adaptor related protein complex 2 subunit alpha 2 |
increases expression |
ISO |
Vitamin E results in increased expression of AP2A2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:214,534,217...214,607,497
Ensembl chr 1:214,534,284...214,606,169
|
|
G |
Ap2m1 |
adaptor related protein complex 2 subunit mu 1 |
increases expression |
ISO |
Vitamin E results in increased expression of AP2M1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:84,041,184...84,047,542
Ensembl chr11:84,041,184...84,047,546
|
|
G |
Ap2s1 |
adaptor related protein complex 2 subunit sigma 1 |
increases expression |
ISO |
Vitamin E results in increased expression of AP2S1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:78,671,238...78,682,847
Ensembl chr 1:78,671,121...78,682,871
|
|
G |
Ap3s2 |
adaptor related protein complex 3 subunit sigma 2 |
increases expression |
ISO |
Vitamin E results in increased expression of AP3S2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:141,612,961...141,655,417
Ensembl chr 1:141,612,963...141,655,894
|
|
G |
Apbb2 |
amyloid beta precursor protein binding family B member 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of APBB2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:43,205,047...43,526,968
Ensembl chr14:43,512,901...43,523,080
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
increases expression |
ISO |
Vitamin E results in increased expression of APEX1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:27,849,943...27,852,083
Ensembl chr15:27,849,979...27,852,082
|
|
G |
Apex2 |
apurinic/apyrimidinic endodeoxyribonuclease 2 |
multiple interactions decreases expression |
EXP |
alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of APEX2 mRNA] alpha-Tocopherol results in decreased expression of APEX2 mRNA |
CTD |
PMID:26332274 |
|
NCBI chr X:23,146,085...23,166,676
Ensembl chr X:23,146,085...23,166,675
|
|
G |
Aplp2 |
amyloid beta precursor like protein 2 |
increases expression |
ISO |
Vitamin E results in increased expression of APLP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:32,298,526...32,328,821
Ensembl chr 8:32,298,532...32,328,839
|
|
G |
Apoa1 |
apolipoprotein A1 |
decreases expression increases expression decreases activity |
ISO EXP |
alpha-Tocopherol results in decreased expression of APOA1 mRNA; alpha-Tocopherol results in decreased expression of APOA1 protein Vitamin E results in increased expression of APOA1 protein alpha-Tocopherol results in decreased activity of APOA1 promoter |
CTD |
PMID:16423621 PMID:18458655 |
|
NCBI chr 8:50,525,091...50,526,875
Ensembl chr 8:50,525,091...50,526,875
|
|
G |
Apob |
apolipoprotein B |
multiple interactions |
ISO |
[Eicosapentaenoic Acid co-treated with Docosahexaenoic Acids co-treated with Oleic Acid co-treated with Folic Acid co-treated with Vitamin B 6 co-treated with Vitamin E] results in decreased expression of APOB protein; alpha-Tocopherol promotes the reaction [APOB protein results in increased reduction of Copper]; Vitamin E promotes the reaction [Flavonoids inhibits the reaction [Copper results in increased oxidation of APOB protein]]; Vitamin E promotes the reaction [Quercetin inhibits the reaction [Copper results in increased oxidation of APOB protein]] |
CTD |
PMID:11368321 PMID:17237316 PMID:17475462 |
|
NCBI chr 6:33,176,826...33,216,381
Ensembl chr 6:33,176,778...33,224,997
|
|
G |
Apoe |
apolipoprotein E |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [APOE mutant form results in increased abundance of 8,12-iso-isoprostane F2alpha-VI] |
CTD |
PMID:16303615 |
|
NCBI chr 1:80,612,894...80,616,820
Ensembl chr 1:80,612,895...80,617,057
|
|
G |
Apol3 |
apolipoprotein L, 3 |
increases expression |
ISO |
Vitamin E results in increased expression of APOL3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:118,685,022...118,694,016
Ensembl chr 7:118,685,022...118,694,015
|
|
G |
Apom |
apolipoprotein M |
increases expression |
ISO |
Vitamin E results in increased expression of APOM mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:5,120,473...5,123,073
Ensembl chr20:5,120,474...5,123,073
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions decreases expression |
ISO EXP |
alpha-Tocopherol inhibits the reaction [APP protein results in increased activity of MAPK14 protein]; alpha-Tocopherol inhibits the reaction [APP protein results in increased activity of MAPK8 protein] Vitamin E inhibits the reaction [APP protein modified form promotes the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of NOS2 protein]]; Vitamin E inhibits the reaction [APP protein results in increased activity of CASP3] Vitamin E inhibits the reaction [Aluminum results in increased cleavage of APP protein] Vitamin E results in decreased expression of APP mRNA |
CTD |
PMID:12039845 PMID:12117551 PMID:12684028 PMID:15223066 PMID:19244175 |
|
NCBI chr11:24,425,013...24,641,872
Ensembl chr11:24,425,005...24,641,858
|
|
G |
Appbp2 |
amyloid beta precursor protein binding protein 2 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of APPBP2 mRNA Vitamin E results in increased expression of APPBP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:72,503,347...72,545,141
Ensembl chr10:72,503,347...72,545,141
|
|
G |
Aqp1 |
aquaporin 1 |
increases expression |
ISO |
Vitamin E results in increased expression of AQP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:85,551,503...85,563,683
Ensembl chr 4:85,551,502...85,569,360
|
|
G |
Aqp3 |
aquaporin 3 (Gill blood group) |
increases expression multiple interactions |
ISO |
Vitamin E results in increased expression of AQP3 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of AQP3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:57,423,735...57,429,252
Ensembl chr 5:57,423,734...57,429,245
|
|
G |
Aqp4 |
aquaporin 4 |
multiple interactions |
EXP ISO |
Vitamin E inhibits the reaction [manganese(III) acetate dihydrate results in increased expression of AQP4 protein] Vitamin E inhibits the reaction [[ferrous chloride results in increased abundance of Iron] which results in increased expression of AQP4 protein] |
CTD |
PMID:20648640 PMID:30914277 |
|
NCBI chr18:6,766,009...6,782,757
Ensembl chr18:6,765,945...6,782,996
|
|
G |
Araf |
A-Raf proto-oncogene, serine/threonine kinase |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ARAF mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:1,369,534...1,391,603
Ensembl chr X:1,379,194...1,390,873
|
|
G |
Arf3 |
ADP-ribosylation factor 3 |
increases expression |
ISO |
Vitamin E results in increased expression of ARF3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:140,412,463...140,438,751
Ensembl chr 7:140,398,199...140,437,467
|
|
G |
Arf5 |
ADP-ribosylation factor 5 |
increases expression |
ISO |
Vitamin E results in increased expression of ARF5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:55,715,744...55,718,670
Ensembl chr 4:55,715,744...55,718,670
|
|
G |
Arhgap10 |
Rho GTPase activating protein 10 |
increases expression |
ISO |
Vitamin E results in increased expression of ARHGAP10 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:34,138,978...34,406,593
Ensembl chr19:34,139,997...34,402,436
|
|
G |
Arhgap8 |
Rho GTPase activating protein 8 |
increases expression |
ISO |
Vitamin E results in increased expression of ARHGAP8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:125,732,300...125,797,149
Ensembl chr 7:125,731,275...125,795,980
|
|
G |
Arhgdia |
Rho GDP dissociation inhibitor alpha |
increases expression |
ISO |
Vitamin E results in increased expression of ARHGDIA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:109,754,012...109,757,506
Ensembl chr10:109,754,004...109,757,550
|
|
G |
Arih1 |
ariadne RBR E3 ubiquitin protein ligase 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ARIH1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:64,166,359...64,268,555
Ensembl chr 8:64,166,360...64,268,555
|
|
G |
Arl4d |
ADP-ribosylation factor like GTPase 4D |
increases expression |
ISO |
Vitamin E results in increased expression of ARL4D mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:89,577,556...89,580,368
Ensembl chr10:89,578,212...89,580,368
|
|
G |
Arl6ip4 |
ADP-ribosylation factor like GTPase 6 interacting protein 4 |
increases expression |
ISO |
Vitamin E results in increased expression of ARL6IP4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:37,904,376...37,906,521
Ensembl chr12:37,904,379...37,906,521
|
|
G |
Arpc1a |
actin related protein 2/3 complex, subunit 1A |
increases expression |
ISO |
Vitamin E results in increased expression of ARPC1A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:11,272,609...11,294,084
Ensembl chr12:11,272,609...11,294,058
|
|
G |
Arpc4 |
actin related protein 2/3 complex, subunit 4 |
increases expression |
ISO |
Vitamin E results in increased expression of ARPC4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:145,330,457...145,340,985
Ensembl chr 4:145,330,457...145,340,984
|
|
G |
Asap3 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 |
increases expression |
ISO |
Vitamin E results in increased expression of ASAP3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:154,551,901...154,596,125
Ensembl chr 5:154,552,195...154,594,785
|
|
G |
Asb1 |
ankyrin repeat and SOCS box-containing 1 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ASB1 mRNA Vitamin E results in increased expression of ASB1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:98,668,231...98,689,471
Ensembl chr 9:98,668,231...98,684,900
|
|
G |
Asxl1 |
ASXL transcriptional regulator 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ASXL1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:148,832,231...148,902,356
Ensembl chr 3:148,837,814...148,900,452
|
|
G |
Atf2 |
activating transcription factor 2 |
multiple interactions increases phosphorylation |
ISO |
alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased phosphorylation of ATF2 protein] Vitamin E results in increased phosphorylation of ATF2 protein |
CTD |
PMID:11522656 PMID:14645110 |
|
NCBI chr 3:60,721,137...60,795,951
Ensembl chr 3:60,721,135...60,795,951
|
|
G |
Atf3 |
activating transcription factor 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ATF3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:109,817,892...109,849,632
Ensembl chr13:109,817,728...109,849,632
|
|
G |
Atf5 |
activating transcription factor 5 |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ATF5 mRNA Vitamin E results in increased expression of ATF5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:100,807,821...100,812,410
Ensembl chr 1:100,808,241...100,810,522
|
|
G |
Atg12 |
autophagy related 12 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ATG12 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:40,721,799...40,732,143
Ensembl chr18:40,721,800...40,732,126
|
|
G |
Atmin |
ATM interactor |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of ATMIN mRNA Vitamin E results in decreased expression of ATMIN mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:49,482,482...49,499,682
|
|
G |
Atox1 |
antioxidant 1 copper chaperone |
increases expression |
ISO |
Vitamin E results in increased expression of ATOX1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:40,790,850...40,805,886
Ensembl chr10:40,790,845...40,805,941
|
|
G |
Atp5f1b |
ATP synthase F1 subunit beta |
increases expression |
ISO |
Vitamin E results in increased expression of ATP5F1B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:2,504,708...2,511,748
Ensembl chr 7:2,504,695...2,511,749
|
|
G |
Atp5f1c |
ATP synthase F1 subunit gamma |
decreases expression |
ISO |
Vitamin E results in decreased expression of ATP5F1C mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:72,209,321...72,231,562
Ensembl chr17:72,209,373...72,394,271
|
|
G |
Atp5me |
ATP synthase membrane subunit e |
decreases expression |
ISO |
Vitamin E results in decreased expression of ATP5ME mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:2,325,308...2,326,436
Ensembl chr14:2,325,308...2,326,436
|
|
G |
Atp6ap2 |
ATPase H+ transporting accessory protein 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ATP6AP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:11,137,889...11,164,854
Ensembl chr X:11,136,939...11,164,915
|
|
G |
Atp6v0d1 |
ATPase H+ transporting V0 subunit D1 |
increases expression |
ISO |
Vitamin E results in increased expression of ATP6V0D1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:37,481,782...37,525,762
Ensembl chr19:37,481,782...37,525,762
|
|
G |
Atp6v1c1 |
ATPase H+ transporting V1 subunit C1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ATP6V1C1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:77,678,853...77,716,658
Ensembl chr 7:77,678,968...77,716,408
|
|
G |
Atp8b1 |
ATPase phospholipid transporting 8B1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ATP8B1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:60,013,388...60,152,920
Ensembl chr18:60,013,382...60,095,354
|
|
G |
Atrx |
ATRX, chromatin remodeler |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of ATRX mRNA [Selenium co-treated with Vitamin E] results in decreased expression of ATRX mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:76,820,110...76,979,155
Ensembl chr X:76,692,970...76,708,878 Ensembl chr X:76,692,970...76,708,878
|
|
G |
Atxn3 |
ataxin 3 |
decreases expression |
ISO |
Vitamin E results in decreased expression of ATXN3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:125,817,420...125,853,461
Ensembl chr 6:125,819,640...125,853,461
|
|
G |
Atxn7 |
ataxin 7 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of ATXN7 mRNA Vitamin E results in decreased expression of ATXN7 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:12,421,432...12,569,649
Ensembl chr15:12,425,175...12,513,931
|
|
G |
Auts2 |
activator of transcription and developmental regulator AUTS2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of AUTS2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:27,155,362...28,252,752
Ensembl chr12:28,212,333...28,251,816
|
|
G |
Axl |
Axl receptor tyrosine kinase |
decreases expression |
ISO |
Vitamin E results in decreased expression of AXL mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:82,550,892...82,580,761
Ensembl chr 1:82,549,420...82,580,761
|
|
G |
Baat |
bile acid CoA:amino acid N-acyltransferase |
increases expression |
EXP |
Vitamin E results in increased expression of BAAT mRNA |
CTD |
PMID:28923436 |
|
NCBI chr 5:64,768,397...64,777,368
Ensembl chr 5:64,768,401...64,777,368
|
|
G |
Babam1 |
BRISC and BRCA1 A complex member 1 |
increases expression |
ISO |
Vitamin E results in increased expression of BABAM1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:19,792,720...19,798,886
Ensembl chr16:19,792,838...19,798,894
|
|
G |
Babam2 |
BRISC and BRCA1 A complex member 2 |
increases expression |
ISO |
Vitamin E results in increased expression of BABAM2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:25,666,654...26,135,888
Ensembl chr 6:25,666,655...26,051,229
|
|
G |
Bace1 |
beta-secretase 1 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [Oxygen deficiency results in increased expression of BACE1 mRNA] |
CTD |
PMID:19196431 |
|
NCBI chr 8:50,140,092...50,162,388
Ensembl chr 8:50,139,997...50,162,361
|
|
G |
Bad |
BCL2-associated agonist of cell death |
increases expression |
EXP |
alpha-Tocopherol results in increased expression of BAD mRNA |
CTD |
PMID:26332274 |
|
NCBI chr 1:222,198,516...222,207,459
Ensembl chr 1:222,198,534...222,207,453
|
|
G |
Bag5 |
BAG cochaperone 5 |
decreases expression |
ISO |
Vitamin E results in decreased expression of BAG5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:136,180,640...136,185,651
Ensembl chr 6:136,182,006...136,185,651
|
|
G |
Bag6 |
BAG cochaperone 6 |
increases expression |
ISO |
Vitamin E results in increased expression of BAG6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:5,124,512...5,138,084
Ensembl chr20:5,125,349...5,138,084
|
|
G |
Banf1 |
BAF nuclear assembly factor 1 |
increases expression |
ISO |
Vitamin E results in increased expression of BANF1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:220,744,195...220,746,224
Ensembl chr 1:220,744,195...220,746,224
|
|
G |
Bap1 |
Brca1 associated protein 1 |
increases expression |
ISO |
Vitamin E results in increased expression of BAP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:7,336,685...7,345,511
Ensembl chr16:7,336,685...7,345,511
|
|
G |
Bard1 |
BRCA1 associated RING domain 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of BARD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:78,297,723...78,368,777
Ensembl chr 9:78,294,834...78,369,031
|
|
G |
Batf |
basic leucine zipper ATF-like transcription factor |
increases expression |
ISO |
Vitamin E results in increased expression of BATF mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:109,562,415...109,584,541
Ensembl chr 6:109,562,587...109,584,545
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions affects expression |
EXP ISO |
alpha-Tocopherol results in increased expression of BAX mRNA [Vitamin E co-treated with Folic Acid] affects the expression of BAX protein; alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in increased expression of BAX protein]; Vitamin E inhibits the reaction [Diazinon results in increased expression of BAX mRNA]; Vitamin E inhibits the reaction [Diazinon results in increased expression of BAX protein]; Vitamin E inhibits the reaction [Nanotubes, Carbon results in increased expression of BAX protein] Vitamin E affects the expression of BAX protein Vitamin E results in increased expression of BAX protein alpha-Tocopherol affects the reaction [Lipopolysaccharides results in increased expression of BAX protein]; Vitamin E inhibits the reaction [cinnamic aldehyde results in increased expression of BAX protein]; Vitamin E inhibits the reaction [Curcumin results in decreased expression of BAX protein]; Vitamin E inhibits the reaction [phenethyl isothiocyanate results in increased expression of BAX protein] |
CTD |
PMID:11166918 PMID:11805214 PMID:15566391 PMID:16054126 PMID:16933212 PMID:22020378 PMID:23523949 PMID:26332274 PMID:27353299 PMID:30935902 PMID:32134168 |
|
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
|
|
G |
Baz1a |
bromodomain adjacent to zinc finger domain, 1A |
decreases expression |
ISO |
Vitamin E results in decreased expression of BAZ1A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 6:75,793,223...75,873,854
Ensembl chr 6:75,793,960...75,874,235
|
|
G |
Baz1b |
bromodomain adjacent to zinc finger domain, 1B |
increases expression |
ISO |
Vitamin E results in increased expression of BAZ1B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr12:24,478,882...24,536,851
Ensembl chr12:24,478,898...24,537,313
|
|
G |
Bbx |
BBX high mobility group box domain containing |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of BBX mRNA Vitamin E results in decreased expression of BBX mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:52,983,286...53,228,557
Ensembl chr11:53,081,025...53,228,716
|
|
G |
Bcap31 |
B-cell receptor-associated protein 31 |
increases expression |
ISO |
Vitamin E results in increased expression of BCAP31 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr X:157,094,365...157,126,397
Ensembl chr X:157,095,937...157,126,393
|
|
G |
Bche |
butyrylcholinesterase |
multiple interactions |
ISO |
[Resveratrol co-treated with Ascorbic Acid co-treated with Thioctic Acid co-treated with Vitamin E] results in increased activity of BCHE protein; alpha-Tocopherol inhibits the reaction [Endosulfan results in decreased activity of BCHE protein]; Hexachlorocyclohexane inhibits the reaction [[Resveratrol co-treated with Ascorbic Acid co-treated with Thioctic Acid co-treated with Vitamin E] results in increased activity of BCHE protein] |
CTD |
PMID:20663516 PMID:24299906 |
|
NCBI chr 2:171,104,476...171,196,186
Ensembl chr 2:171,100,140...171,196,395
|
|
G |
Bcl11a |
BAF chromatin remodeling complex subunit BCL11A |
decreases expression |
ISO |
Vitamin E results in decreased expression of BCL11A mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:108,826,717...108,921,197
Ensembl chr14:108,826,831...108,921,669
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression increases expression multiple interactions |
ISO EXP |
alpha-Tocopherol analog results in decreased expression of BCL2 mRNA; alpha-Tocopherol analog results in decreased expression of BCL2 protein Vitamin E results in increased expression of BCL2 mRNA [Vitamin E co-treated with Folic Acid] affects the expression of BCL2 protein; alpha-Tocopherol inhibits the reaction [mancozeb results in decreased expression of BCL2 protein]; alpha-Tocopherol inhibits the reaction [Triiodothyronine, Reverse results in increased activity of BCL2 protein]; Vitamin E inhibits the reaction [Nanotubes, Carbon results in decreased expression of BCL2 protein] [Vitamin E co-treated with Curcumin] results in decreased expression of BCL2 protein; alpha-Tocopherol affects the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]; benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein]; DDIT3 mRNA affects the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein]; salubrinal inhibits the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein]; TNFRSF10B mRNA affects the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein]; Vitamin E inhibits the reaction [cinnamic aldehyde results in decreased expression of BCL2 protein] |
CTD |
PMID:11805214 PMID:15566391 PMID:16005924 PMID:16135673 PMID:16933212 PMID:20686688 PMID:22020378 PMID:27353299 PMID:30935902 |
|
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression increases expression multiple interactions |
EXP ISO |
alpha-Tocopherol results in decreased expression of BCL2L1 protein Vitamin E results in increased expression of BCL2L1 mRNA [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of BCL2L1 mRNA |
CTD |
PMID:11444866 PMID:18942769 PMID:19244175 |
|
NCBI chr 3:148,259,594...148,314,191
Ensembl chr 3:148,259,596...148,313,810
|
|
G |
Bcl6 |
BCL6, transcription repressor |
decreases expression |
ISO |
Vitamin E results in decreased expression of BCL6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:80,255,790...80,279,075
Ensembl chr11:80,255,790...80,279,075
|
|
G |
Bclaf1 |
BCL2-associated transcription factor 1 |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of BCLAF1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of BCLAF1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:15,799,753...15,828,838
Ensembl chr 1:15,782,477...15,860,624
|
|
G |
Bco1 |
beta-carotene oxygenase 1 |
multiple interactions |
EXP |
Vitamin E inhibits the reaction [Oxidants inhibits the reaction [BCO1 protein results in increased oxidation of beta Carotene]] |
CTD |
PMID:9526112 |
|
NCBI chr19:49,637,059...49,673,577
Ensembl chr19:49,637,016...49,673,808
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions |
ISO |
[alpha-Tocopherol co-treated with Nimodipine] inhibits the reaction [Dibutyl Phthalate results in decreased expression of BDNF protein] |
CTD |
PMID:30776390 |
|
NCBI chr 3:100,768,637...100,819,216
Ensembl chr 3:100,768,637...100,819,210
|
|
G |
Becn1 |
beclin 1 |
multiple interactions decreases expression |
EXP |
Vitamin E inhibits the reaction [Pilocarpine results in increased expression of BECN1 mRNA]; Vitamin E inhibits the reaction [Pilocarpine results in increased expression of BECN1 protein] Vitamin E results in decreased expression of BECN1 protein |
CTD |
PMID:19138675 |
|
NCBI chr10:89,209,944...89,225,297
Ensembl chr10:89,209,940...89,225,297
|
|
G |
Bicd1 |
BICD cargo adaptor 1 |
decreases expression multiple interactions |
ISO |
Vitamin E results in decreased expression of BICD1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of BICD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:184,018,845...184,167,628
Ensembl chr 4:184,019,087...184,165,540
|
|
G |
Bicd2 |
BICD cargo adaptor 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of BICD2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:15,673,649...15,718,035
Ensembl chr17:15,673,650...15,718,035
|
|
G |
Bin1 |
bridging integrator 1 |
increases expression |
ISO |
Vitamin E results in increased expression of BIN1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr18:25,163,575...25,222,139
Ensembl chr18:25,163,561...25,222,135
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
multiple interactions |
EXP ISO |
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of BIRC2 mRNA Vitamin E inhibits the reaction [cinnamic aldehyde results in decreased expression of BIRC2 protein] |
CTD |
PMID:11444866 PMID:15566391 |
|
NCBI chr 8:6,014,014...6,036,668
Ensembl chr 8:6,013,207...6,034,142
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [cinnamic aldehyde results in decreased expression of BIRC3 protein] |
CTD |
PMID:15566391 |
|
NCBI chr 8:6,048,590...6,076,828
Ensembl chr 8:6,048,969...6,076,598
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [Benzo(a)pyrene results in decreased expression of BIRC5 protein] |
CTD |
PMID:24664296 |
|
NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
|
|
G |
Bles03 |
basophilic leukemia expressed protein BLES03 |
increases expression |
ISO |
Vitamin E results in increased expression of C11ORF68 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:220,806,563...220,808,817
Ensembl chr 1:220,806,473...220,808,804
|
|
G |
Blvra |
biliverdin reductase A |
increases expression |
ISO |
Vitamin E results in increased expression of BLVRA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:119,552,550...119,577,796
Ensembl chr 3:119,561,290...119,577,806
|
|
G |
Bmp2k |
BMP-2 inducible kinase |
decreases expression |
ISO |
Vitamin E results in decreased expression of BMP2K mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:14,126,086...14,226,823
Ensembl chr14:14,129,725...14,192,048
|
|
G |
Bmp4 |
bone morphogenetic protein 4 |
increases expression |
ISO |
Vitamin E results in increased expression of BMP4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:20,776,060...20,791,013
Ensembl chr15:20,776,054...20,822,740
|
|
G |
Bptf |
bromodomain PHD finger transcription factor |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of BPTF mRNA Vitamin E results in decreased expression of BPTF mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:95,248,573...95,350,162
Ensembl chr10:95,250,294...95,349,789
|
|
G |
Brd2 |
bromodomain containing 2 |
multiple interactions decreases expression increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of BRD2 mRNA Vitamin E results in decreased expression of BRD2 mRNA Vitamin E results in increased expression of BRD2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:3,910,555...3,921,074
Ensembl chr20:3,910,555...3,917,426 Ensembl chr20:3,910,555...3,917,426
|
|
G |
Brf2 |
BRF2, RNA polymerase III transcription initiation factor subunit |
increases expression |
ISO |
Vitamin E results in increased expression of BRF2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:69,089,955...69,094,678
Ensembl chr16:69,089,955...69,094,680
|
|
G |
Brms1 |
BRMS1, transcriptional repressor and anoikis regulator |
increases expression |
ISO |
Vitamin E results in increased expression of BRMS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:220,325,352...220,334,616
|
|
G |
Bscl2 |
BSCL2 lipid droplet biogenesis associated, seipin |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of BSCL2 mRNA Vitamin E results in increased expression of BSCL2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:225,035,956...225,046,137
Ensembl chr 1:225,037,737...225,046,040
|
|
G |
Bst2 |
bone marrow stromal cell antigen 2 |
increases expression |
ISO |
Vitamin E results in increased expression of BST2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:19,938,781...19,942,353
Ensembl chr16:19,938,784...19,942,353
|
|
G |
C1s |
complement C1s |
increases expression |
ISO |
Vitamin E results in increased expression of C1S mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:157,143,592...157,155,592
Ensembl chr 4:157,143,592...157,155,609
|
|
G |
Ca3 |
carbonic anhydrase 3 |
multiple interactions |
EXP |
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of CA3 mRNA |
CTD |
PMID:11444866 |
|
NCBI chr 2:88,126,519...88,136,063
Ensembl chr 2:88,126,667...88,135,410
|
|
G |
Caap1 |
caspase activity and apoptosis inhibitor 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CAAP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:113,479,416...113,532,961
Ensembl chr 5:113,480,547...113,532,878
|
|
G |
Cab39 |
calcium binding protein 39 |
increases expression |
ISO |
Vitamin E results in increased expression of MO25 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 9:92,834,327...92,895,778
Ensembl chr 9:92,834,357...92,895,778
|
|
G |
Cald1 |
caldesmon 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CALD1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:62,103,948...62,291,375
Ensembl chr 4:62,220,736...62,291,489
|
|
G |
Calm3 |
calmodulin 3 |
increases expression |
ISO |
Vitamin E results in increased expression of CALM3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:78,844,520...78,851,628
Ensembl chr 1:78,843,080...78,851,719
|
|
G |
Calr |
calreticulin |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CALR mRNA Vitamin E results in decreased expression of CALR mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:25,956,771...25,961,666
Ensembl chr19:25,956,771...25,961,666
|
|
G |
Calu |
calumenin |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CALU mRNA Vitamin E results in increased expression of CALU mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:56,625,611...56,653,112
Ensembl chr 4:56,625,561...56,653,111
|
|
G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
increases expression |
ISO |
Vitamin E results in increased expression of CAMK2B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:86,208,876...86,297,727
Ensembl chr14:86,208,901...86,297,652
|
|
G |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
decreases expression |
ISO |
Vitamin E results in decreased expression of CAMK2G mRNA |
CTD |
PMID:19244175 |
|
NCBI chr15:3,936,721...3,995,740
Ensembl chr15:3,936,786...3,995,915
|
|
G |
Canx |
calnexin |
affects localization increases expression |
EXP |
alpha-Tocopherol affects the localization of CANX protein alpha-Tocopherol results in increased expression of CANX mRNA; alpha-Tocopherol results in increased expression of CANX protein |
CTD |
PMID:16908007 |
|
NCBI chr10:35,800,942...35,833,939
Ensembl chr10:35,800,942...35,833,861
|
|
G |
Cap1 |
cyclase associated actin cytoskeleton regulatory protein 1 |
increases expression |
ISO |
Vitamin E results in increased expression of CAP1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:140,559,195...140,585,494
Ensembl chr 5:140,559,206...140,585,408
|
|
G |
Capg |
capping actin protein, gelsolin like |
increases expression |
ISO |
Vitamin E results in increased expression of CAPG mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:100,395,693...100,419,447
Ensembl chr 4:100,407,658...100,419,446
|
|
G |
Capn7 |
calpain 7 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CAPN7 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:7,435,541...7,472,483
Ensembl chr16:7,435,634...7,471,807
|
|
G |
Capns1 |
calpain, small subunit 1 |
increases expression |
ISO |
Vitamin E results in increased expression of CAPNS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:91,058,528...91,064,880
|
|
G |
Caprin2 |
caprin family member 2 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CAPRIN2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 4:183,304,993...183,374,195
Ensembl chr 4:183,305,813...183,374,195
|
|
G |
Capzb |
capping actin protein of muscle Z-line subunit beta |
increases expression |
ISO |
Vitamin E results in increased expression of CAPZB mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 5:157,642,742...157,742,487
Ensembl chr 5:157,642,751...157,742,478
|
|
G |
Casc3 |
CASC3 exon junction complex subunit |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of MLN51 mRNA Vitamin E results in increased expression of MLN51 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:86,724,534...86,744,485
Ensembl chr10:86,724,427...86,745,927
|
|
G |
Casp3 |
caspase 3 |
decreases activity multiple interactions |
ISO EXP |
alpha-Tocopherol results in decreased activity of CASP3 protein [alpha-Tocopherol co-treated with Nimodipine] inhibits the reaction [Dibutyl Phthalate results in increased expression of CASP3 protein]; alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in increased cleavage of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of CASP3 protein]; Vitamin E inhibits the reaction [titanium dioxide results in increased activity of CASP3 protein] [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of CASP3 protein]; [Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Dichlorvos results in increased activity of CASP3 protein]; [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of CASP3 mRNA]; alpha-Tocopherol inhibits the reaction [Diclofenac results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in increased expression of CASP3 protein]; Vitamin E inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [APP protein results in increased activity of CASP3]; Vitamin E inhibits the reaction [Diazinon results in increased activity of CASP3 protein]; Vitamin E inhibits the reaction [Diazinon results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [Diazinon results in increased expression of CASP3 protein modified form]; Vitamin E inhibits the reaction [Nanotubes, Carbon results in increased activity of CASP3 protein] [alpha-Tocopherol co-treated with beta-ionone] results in increased activity of CASP3 protein; [alpha-Tocopherol co-treated with Tretinoin] results in increased activity of CASP3 protein; alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Acetaldehyde results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [cholest-5-en-3 beta,7 alpha-diol results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Galactosamine results in increased cleavage of and results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [S-(1,2-dichlorovinyl)cysteine results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Vitamin A results in increased activity of CASP3 protein]; alpha-Tocopherol promotes the reaction [Amiodarone results in increased activity of CASP3 protein]; alpha-Tocopherol promotes the reaction [beta Carotene metabolite results in decreased activity of CASP3 protein]; alpha-Tocopherol promotes the reaction [TNF protein promotes the reaction [Amiodarone results in increased activity of CASP3 protein]]; alpha-Tocopherol results in increased cleavage of and results in increased activity of CASP3 protein; Vitamin E inhibits the reaction [cinnamic aldehyde results in increased activity of CASP3 protein]; Vitamin E inhibits the reaction [Curcumin results in decreased expression of CASP3 protein]; Vitamin E inhibits the reaction [osimertinib results in increased expression of CASP3 protein modified form]; Vitamin E inhibits the reaction [phenethyl isothiocyanate results in increased activity of CASP3 protein] |
CTD |
PMID:12117551 PMID:12450566 PMID:14599462 PMID:14722101 PMID:15095415 PMID:15566391 PMID:16054126 PMID:16973328 PMID:17618090 PMID:17874176 PMID:17936189 PMID:21628957 PMID:21869839 PMID:21873648 PMID:22020378 PMID:22389237 PMID:23042730 PMID:23523949 PMID:27353299 PMID:28237877 PMID:29065513 PMID:29129777 PMID:30626778 PMID:30776390 PMID:30935902 PMID:31712109 PMID:32134168 |
|
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Casp7 |
caspase 7 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [S-(1,2-dichlorovinyl)cysteine results in increased activity of CASP7 protein]; alpha-Tocopherol promotes the reaction [Amiodarone results in increased activity of CASP7 protein]; alpha-Tocopherol promotes the reaction [TNF protein promotes the reaction [Amiodarone results in increased activity of CASP7 protein]] |
CTD |
PMID:23042730 PMID:29129777 |
|
NCBI chr 1:277,190,557...277,242,779
Ensembl chr 1:277,190,964...277,242,774
|
|
G |
Casp8 |
caspase 8 |
increases cleavage |
ISO |
alpha-Tocopherol analog results in increased cleavage of CASP8 protein |
CTD |
PMID:20686688 |
|
NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106
|
|
G |
Casp9 |
caspase 9 |
increases cleavage multiple interactions increases expression |
ISO EXP |
alpha-Tocopherol analog results in increased cleavage of CASP9 protein alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of CASP9 protein] [Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Dichlorvos results in increased activity of CASP9 protein]; [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of CASP9 mRNA]; Vitamin E inhibits the reaction [Diazinon results in increased cleavage of CASP9 protein] Vitamin E results in increased expression of CASP9 mRNA alpha-Tocopherol results in increased cleavage of and results in increased activity of CASP9 protein |
CTD |
PMID:16973328 PMID:19244175 PMID:20686688 PMID:21628957 PMID:21869839 PMID:27353299 PMID:31712109 |
|
NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
|
|
G |
Cat |
catalase |
increases expression multiple interactions decreases activity affects expression increases activity |
ISO EXP |
alpha-Tocopherol results in increased expression of CAT mRNA; alpha-Tocopherol results in increased expression of CAT protein alpha-Tocopherol results in increased expression of CAT protein; Vitamin E results in increased expression of CAT protein [Ascorbic Acid co-treated with beta Carotene co-treated with alpha-Tocopherol co-treated with Sodium Selenite] inhibits the reaction [Galactosamine results in increased activity of CAT protein]; [Curcumin co-treated with Vitamin E] inhibits the reaction [Thyroxine results in decreased expression of CAT mRNA]; [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; [Selenium co-treated with Vitamin E] inhibits the reaction [Malathion results in decreased activity of CAT protein]; [Sodium Selenite co-treated with alpha-Tocopherol] inhibits the reaction [bisphenol A results in decreased activity of CAT protein]; [Vitamin E co-treated with coenzyme Q10] inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein]; [Vitamin E co-treated with coenzyme Q10] results in increased activity of CAT protein; [Vitamin E co-treated with Curcumin] inhibits the reaction [Thyroxine results in decreased activity of CAT protein]; [Vitamin E co-treated with Quercetin] inhibits the reaction [Cyclosporine results in decreased activity of CAT protein]; [Vitamin E co-treated with Sodium Selenite] inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]; [Vitamin E inhibits the reaction [Nanotubes, Carbon results in decreased activity of CAT protein]] which affects the abundance of Reactive Oxygen Species; [Zinc co-treated with Vitamin E co-treated with Ascorbic Acid co-treated with sodium arsenite] results in increased activity of CAT protein; alpha-Tocopherol affects the reaction [Copper Sulfate results in decreased activity of CAT protein]; alpha-Tocopherol affects the reaction [flubendiamide results in decreased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [cholestane-3,5,6-triol results in decreased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [Malathion results in increased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [Streptozocin results in decreased expression of CAT protein]; Ginkgo biloba extract promotes the reaction [Vitamin E inhibits the reaction [endotoxin, Escherichia coli results in decreased activity of CAT protein]]; Vitamin E inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Cadmium results in increased activity of CAT protein]; Vitamin E inhibits the reaction [Carbofuran results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [chromium hexavalent ion results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Cyclosporine results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Dimethoate results in increased activity of CAT protein]; Vitamin E inhibits the reaction [endotoxin, Escherichia coli results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Food Additives affects the activity of CAT protein]; Vitamin E inhibits the reaction [Formaldehyde results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Malathion results in increased activity of CAT protein]; Vitamin E inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Methoxychlor results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Nanotubes, Carbon results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Petroleum results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Potassium Dichromate results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Tetrachlorodibenzodioxin results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Thyroxine results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Thyroxine results in decreased expression of CAT protein]; Vitamin E promotes the reaction [Ginkgo biloba extract inhibits the reaction [endotoxin, Escherichia coli results in decreased activity of CAT protein]] Vitamin E results in decreased activity of CAT protein [Vitamin E co-treated with coenzyme Q10] inhibits the reaction [sodium arsenite results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Ethanol results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [fipronil results in decreased activity of CAT protein] Vitamin E affects the expression of CAT protein [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Air Pollutants, Occupational affects the expression of CAT protein]; [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Malathion results in increased activity of CAT protein]; [Ascorbic Acid co-treated with Vitamin E] results in increased expression of CAT mRNA; Vitamin E inhibits the reaction [Aluminum results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Dimethoate results in increased activity of CAT protein]; Vitamin E inhibits the reaction [Malathion results in increased activity of CAT protein]; Vitamin E inhibits the reaction [Oleic Acid results in decreased activity of CAT protein] alpha-Tocopherol results in increased activity of CAT protein |
CTD |
PMID:9306888 PMID:11597945 PMID:11834209 PMID:11955947 PMID:12355564 PMID:14535831 PMID:15669049 PMID:15820619 PMID:16144695 PMID:16298753 PMID:16758767 PMID:16937016 PMID:16979807 PMID:17262218 PMID:17383094 PMID:17709913 PMID:17927767 PMID:18547560 PMID:18655177 PMID:19083475 PMID:19464315 PMID:19914224 PMID:19941068 PMID:19958828 PMID:20077558 PMID:20079796 PMID:20194575 PMID:20535553 PMID:21086752 PMID:21322096 PMID:21628957 PMID:21736874 PMID:21787585 PMID:22020378 PMID:22207723 PMID:22732938 PMID:23348005 PMID:23369933 PMID:23619517 PMID:24865641 PMID:25046308 PMID:25721553 PMID:27823922 PMID:29948670 PMID:30057697 PMID:31022331 |
|
NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058
|
|
G |
Cav1 |
caveolin 1 |
multiple interactions |
ISO |
alpha-Tocopherol inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 mRNA] Vitamin E inhibits the reaction [Hydrogen Peroxide results in increased expression of CAV1 protein] |
CTD |
PMID:12134086 PMID:27257344 |
|
NCBI chr 4:44,597,123...44,630,206
Ensembl chr 4:44,597,123...44,630,200
|
|
G |
Cavin1 |
caveolae associated protein 1 |
multiple interactions increases expression |
ISO |
Vitamin E inhibits the reaction [Hydrogen Peroxide results in increased expression of CAVIN1 protein] Vitamin E results in increased expression of CAVIN1 mRNA |
CTD |
PMID:19244175 PMID:21705337 |
|
NCBI chr10:88,862,513...88,874,495
Ensembl chr10:88,860,733...88,874,528
|
|
G |
Cavin3 |
caveolae associated protein 3 |
increases expression |
ISO |
Vitamin E results in increased expression of CAVIN3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:170,317,099...170,318,688
Ensembl chr 1:170,317,113...170,318,935
|
|
G |
Cblb |
Cbl proto-oncogene B |
decreases expression |
ISO |
Vitamin E results in decreased expression of CBLB mRNA |
CTD |
PMID:19244175 |
|
NCBI chr11:51,037,383...51,202,761
Ensembl chr11:51,037,393...51,202,820
|
|
G |
Cbx5 |
chromobox 5 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CBX5 mRNA Vitamin E results in decreased expression of CBX5 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:144,819,673...144,865,014
Ensembl chr 7:144,819,420...144,837,583
|
|
G |
Cbx6 |
chromobox 6 |
increases expression |
ISO |
Vitamin E results in increased expression of CBX6 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:121,047,996...121,058,109
Ensembl chr 7:121,050,302...121,058,029
|
|
G |
Cbx7 |
chromobox 7 |
increases expression |
ISO |
Vitamin E results in increased expression of CBX7 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:121,136,067...121,153,503
Ensembl chr 7:121,136,058...121,153,383
|
|
G |
Cby1 |
chibby family member 1, beta catenin antagonist |
increases expression |
ISO |
Vitamin E results in increased expression of CBY1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:120,891,930...120,898,318
Ensembl chr 7:120,891,940...120,897,687
|
|
G |
Ccdc85b |
coiled-coil domain containing 85B |
multiple interactions increases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of DIPA mRNA Vitamin E results in increased expression of DIPA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:220,835,647...220,837,220
|
|
G |
Cchcr1 |
coiled-coil alpha-helical rod protein 1 |
increases expression |
ISO |
Vitamin E results in increased expression of CCHCR1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:3,730,968...3,745,721
Ensembl chr20:3,730,955...3,740,009
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions increases expression |
ISO EXP |
alpha-Tocopherol inhibits the reaction [Vitamin E deficiency results in increased expression of CCL2 protein]; Quercetin inhibits the reaction [Vitamin E deficiency results in increased expression of CCL2 protein] alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of CCL2 mRNA]; alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] |
CTD |
PMID:19735175 PMID:24333275 PMID:26332274 |
|
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
multiple interactions |
ISO |
[Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3,4-dihydroxyphenylethanol] results in decreased expression of CCL5 mRNA |
CTD |
PMID:16797527 |
|
NCBI chr10:70,739,764...70,744,303
Ensembl chr10:70,739,800...70,744,315
|
|
G |
Ccnd1 |
cyclin D1 |
increases expression multiple interactions affects expression |
ISO EXP |
Vitamin E results in increased expression of CCND1 mRNA Vitamin E inhibits the reaction [Curcumin results in decreased expression of CCND1 protein] Vitamin E affects the expression of CCND1 mRNA; Vitamin E affects the expression of CCND1 protein [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of CCND1 mRNA; alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of CCND1 mRNA] |
CTD |
PMID:11444866 PMID:16298738 PMID:19244175 PMID:26332274 PMID:30935902 |
|
NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325
|
|
G |
Ccnd2 |
cyclin D2 |
multiple interactions increases expression |
EXP ISO |
alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of CCND2 mRNA] Vitamin E results in increased expression of CCND2 mRNA |
CTD |
PMID:19244175 PMID:26332274 |
|
NCBI chr 4:159,674,885...159,697,207
Ensembl chr 4:159,674,885...159,697,207
|
|
G |
Ccnd3 |
cyclin D3 |
affects expression |
EXP |
Vitamin E affects the expression of CCND3 mRNA |
CTD |
PMID:15370891 |
|
NCBI chr 9:15,404,816...15,410,905
Ensembl chr 9:15,404,822...15,410,943
|
|
G |
Ccne1 |
cyclin E1 |
affects expression |
EXP |
Vitamin E affects the expression of CCNE1 mRNA |
CTD |
PMID:16298738 |
|
NCBI chr 1:94,485,830...94,495,112
Ensembl chr 1:94,485,832...94,494,980
|
|
G |
Ccnl1 |
cyclin L1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CCNL1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 2:157,747,295...157,759,838
Ensembl chr 2:157,747,542...157,759,838
|
|
G |
Ccpg1 |
cell cycle progression 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CPR8 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:79,660,634...79,692,044
Ensembl chr 8:79,660,657...79,692,039
|
|
G |
Ccs |
copper chaperone for superoxide dismutase |
increases expression |
ISO |
Vitamin E results in increased expression of CCS mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:220,075,251...220,096,319
Ensembl chr 1:220,075,247...220,096,404
|
|
G |
Cd2bp2 |
Cd2 (cytoplasmic tail) binding protein 2 |
increases expression |
ISO |
Vitamin E results in increased expression of CD2BP2 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 1:198,635,445...198,641,195
Ensembl chr 1:198,635,447...198,638,944
|
|
G |
Cd36 |
CD36 molecule |
affects expression multiple interactions |
EXP |
alpha-Tocopherol affects the expression of CD36 mRNA alpha-Tocopherol inhibits the reaction [[troglitazone co-treated with Ethanol] results in increased expression of CD36 protein] |
CTD |
PMID:16407258 |
|
NCBI chr 4:14,150,309...14,191,498
Ensembl chr 4:14,001,761...14,249,749
|
|
G |
Cd44 |
CD44 molecule (Indian blood group) |
decreases expression |
ISO |
Vitamin E results in decreased expression of CD44 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658
|
|
G |
Cd63 |
Cd63 molecule |
increases expression |
ISO |
Vitamin E results in increased expression of CD63 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:3,320,250...3,335,583
Ensembl chr 7:3,320,103...3,335,582
|
|
G |
Cd86 |
CD86 molecule |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [Dinitrochlorobenzene results in increased expression of CD86 protein]; Vitamin E inhibits the reaction [Ethylmercuric Chloride results in increased expression of CD86 protein]; Vitamin E inhibits the reaction [Thimerosal results in increased expression of CD86 protein] |
CTD |
PMID:20457211 |
|
NCBI chr11:67,060,305...67,117,990
Ensembl chr11:67,082,193...67,118,795
|
|
G |
Cd99 |
CD99 molecule (Xg blood group) |
increases expression |
ISO |
Vitamin E results in increased expression of CD99 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr20:56,192,426...56,196,961
Ensembl chr20:56,192,390...56,197,025
|
|
G |
Cdc14b |
cell division cycle 14B |
decreases expression |
ISO |
Vitamin E results in decreased expression of CDC14B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:1,709,703...1,797,732
Ensembl chr17:1,703,943...1,797,750
|
|
G |
Cdc16 |
cell division cycle 16 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CDC16 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr16:81,493,355...81,516,493
Ensembl chr16:81,493,355...81,516,493
|
|
G |
Cdc25b |
cell division cycle 25B |
increases expression |
ISO |
Vitamin E results in increased expression of CDC25B mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 3:123,731,539...123,741,696
Ensembl chr 3:123,731,539...123,741,339
|
|
G |
Cdc27 |
cell division cycle 27 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CDC27 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr10:92,551,754...92,602,214
Ensembl chr10:92,554,081...92,602,082
|
|
G |
Cdc42bpa |
CDC42 binding protein kinase alpha |
multiple interactions increases expression decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CDC42BPA mRNA Vitamin E results in increased expression of CDC42BPA mRNA Vitamin E results in decreased expression of CDC42BPA mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:98,231,326...98,447,762
Ensembl chr13:98,231,326...98,447,762
|
|
G |
Cdh2 |
cadherin 2 |
multiple interactions |
EXP |
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of CDH2 protein] |
CTD |
PMID:29940330 |
|
NCBI chr18:8,146,971...8,366,037
Ensembl chr18:8,146,971...8,360,684
|
|
G |
Cdh3 |
cadherin 3 |
increases expression |
ISO |
Vitamin E results in increased expression of CDH3 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:38,668,957...38,719,801
Ensembl chr19:38,669,230...38,719,677
|
|
G |
Cdk10 |
cyclin-dependent kinase 10 |
multiple interactions |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CDK10 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr19:56,024,903...56,032,610
Ensembl chr19:56,024,903...56,032,605
|
|
G |
Cdk13 |
cyclin-dependent kinase 13 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CDK13 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr17:49,833,194...49,922,932
Ensembl chr17:49,833,400...49,921,550
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
increases expression |
ISO |
Vitamin E results in increased expression of CDK4 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:70,345,971...70,352,689
Ensembl chr 7:70,349,863...70,352,418
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions affects expression decreases expression |
EXP ISO |
alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of CDKN1A mRNA] Vitamin E inhibits the reaction [Curcumin results in decreased expression of CDKN1A protein] Vitamin E affects the expression of CDKN1A mRNA alpha-Tocopherol results in decreased expression of CDKN1A mRNA |
CTD |
PMID:16298738 PMID:26332274 PMID:30935902 |
|
NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
increases expression |
ISO |
Vitamin E results in increased expression of CDKN1B protein |
CTD |
PMID:12352461 |
|
NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964
|
|
G |
Cds1 |
CDP-diacylglycerol synthase 1 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CDS1 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr14:9,396,511...9,456,964
Ensembl chr14:9,396,512...9,456,990
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
multiple interactions |
ISO |
Vitamin E inhibits the reaction [Ethanol results in decreased activity of CEBPA protein]; Vitamin E inhibits the reaction [Ethanol results in decreased expression of CEBPA protein] |
CTD |
PMID:16737972 |
|
NCBI chr 1:91,363,492...91,366,164
Ensembl chr 1:91,363,492...91,366,164
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
increases response to substance |
ISO |
CEBPB results in increased susceptibility to Vitamin E |
CTD |
PMID:9359698 |
|
NCBI chr 3:164,424,502...164,425,933
Ensembl chr 3:164,424,515...164,425,910
|
|
G |
Cep164 |
centrosomal protein 164 |
increases expression |
ISO |
Vitamin E results in increased expression of CEP164 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:50,069,282...50,132,477
Ensembl chr 8:50,070,579...50,126,413
|
|
G |
Cep170 |
centrosomal protein 170 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CEP170 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:94,807,090...94,887,448
Ensembl chr13:94,807,756...94,859,436
|
|
G |
Cep290 |
centrosomal protein 290 |
decreases expression |
ISO |
Vitamin E results in decreased expression of CEP290 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 7:40,217,269...40,306,327
Ensembl chr 7:40,217,269...40,306,327
|
|
G |
Cep350 |
centrosomal protein 350 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in increased expression of CEP350 mRNA Vitamin E results in decreased expression of CEP350 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr13:73,499,715...73,637,707
Ensembl chr13:73,499,229...73,638,073
|
|
G |
Cep57 |
centrosomal protein 57 |
multiple interactions decreases expression |
ISO |
[Selenium co-treated with Vitamin E] results in decreased expression of CEP57 mRNA Vitamin E results in decreased expression of CEP57 mRNA |
CTD |
PMID:19244175 |
|
NCBI chr 8:12,335,430...12,355,425
Ensembl chr 8:12,335,432...12,355,091
|
| |